Abstract
Tumor-derived exosomes (TDEs) are actively produced and released by tumor cells and carry messages from tumor cells to healthy cells or abnormal cells, and they participate in tumor metastasis. In this review, we explore the underlying mechanism of action of TDEs in tumor metastasis. TDEs transport tumor-derived proteins and non-coding RNA to tumor cells and promote migration. Transport to normal cells, such as vascular endothelial cells and immune cells, promotes angiogenesis, inhibits immune cell activation, and improves chances of tumor implantation. Thus, TDEs contribute to tumor metastasis. We summarize the function of TDEs and their components in tumor metastasis and illuminate shortcomings for advancing research on TDEs in tumor metastasis.
Background
Exosomes are extracellular vesicles, approximately 30–150 nm in diameter, that contain functional biomolecules, such as proteins, RNA, DNA, and lipids, and can interact with recipient cells (Balaj et al., 2011; Choi et al., 2013; Peinado et al., 2011; Raposo and Stoorvogel, 2013; Skog et al., 2008; Thakur et al., 2014; Thery et al., 2009; Valadi et al., 2007). Exosomes are present in various body fluids and are regarded as a key component of intercellular communication. Tumor cell-, stromal cell-, or even normal cell–derived exosomes play an important role in tumor progression and can induce angiogenesis and accelerate metastasis (Hood et al., 2011; Luga et al., 2012; Peinado et al., 2012). The components and functions of the exosomes depend on the cell types; some studies have shown many differences in the contents and release rate in different types of cells. But, the complete mechanism and process have not yet been elucidated and need to be further explored. Metastasis is the leading cause of tumor-induced death and is a complex process involving local invasion, survival, and evasion from immunosurveillance, invasion into circulation, and extravasation at secondary organs (Fidler and Kripke, 2015; Wan et al., 2013). Tumor-derived exosomes (TDEs) are a significant component of the tumor microenvironment and are involved in promoting tumor metastasis through several mechanisms, including acquiring primary tumor migration capacity, tumor angiogenesis, escaping immune system organotropic metastasis, forming the pre-metastatic niche, and metastatic tumor growth in the secondary site.
In this review, we summarize the function of exosomes in every aspect of cancer metastasis (Figure 1) to provide a better systematic comprehension of the role of exosomes in tumor metastasis and propose practical implications of early diagnosis, treatment, and prognostic methods for cancer.
FIGURE 1

Function of TDEs in tumor metastasis. TDEs are mainly involved in tumor metastasis through five aspects. Step 1: acquisition of tumor migration ability; Step 2: angiogenesis; Step 3: immunosuppression; Step 4: localization of metastatic sites; and Step 5: enhancement of proliferation ability of tumor cells after migration.
Tumor-Derived Exosomes Enhance the Migration Ability of Tumor Cells
Tumor-Derived Exosomes Promote Epithelial–Mesenchymal Transition to Initiate Metastasis
Epithelial–mesenchymal transition (EMT) frequently initiates the metastatic process (Li et al., 2021). Epithelial tumor cells acquire mesenchymal characteristics under the influence of cancer-associated fibroblasts (CAFs) in the tumor stroma (Diepenbruck and Christofori, 2016). Epithelial markers, including E-cadherin, zona occludens 1 (ZO-1), cytokeratins, desmoplakin, and laminin, are downregulated, and mesenchymal markers, including N-cadherin, β-catenin, and vimentin, are upregulated (Sommers et al., 1994; Li Y. et al., 2019). During EMT, tumor cells lose their apical–basal polarity, basement anchoring, and cell–cell junctions and switch to a low proliferation state with enhanced migratory and invasion capabilities (Basil et al., 2020). Once the tumor cells reach a distant pre-metastatic niche, the reversed process takes place (Maren, 2016). This so-called mesenchymal–epithelial transition (MET) returns tumor cells to a high proliferative state and enables the formation of micrometastases (Bakir et al., 2019). TDEs play an important regulatory role in mediating the EMT and MET transformation (Bigagli et al., 2019). There has been increasing research showing the signaling pathway involved in inducing cancer-related EMT. We propose that the critical components in TDEs can serve to promote EMT.
The latest hypothesis is TDEs may be conduits for initiating signals for EMT. For example, TDEs carry EMT derivers, such as transforming growth factor-beta (TGF-β), tumor necrosis factor-alpha (TNF-α), hypoxia-inducible factor 1 alpha (HIF-1α), protein kinase B (AKT), caveolin-1, platelet-derived growth factors (PDGFs), and β-catenin Wnt pathway modulators, that directly enhance the process of EMT (Aga et al., 2014; Kucharzewska et al., 2013; Luga et al., 2012; Ramteke et al., 2015). TDEs transmit non-coding RNA, such as, miR-128-3p, miR-27, LINC00960, linc02470, circ-PVT1, and circ-CPA4, that upregulate EMT (Huang C.-S. et al., 2020; Liu et al., 2019; Wang J. et al., 2018). Therefore, many studies have shown that tumor cells can secrete exosomes into the extracellular space and promote the EMT through their effectors: proteins, miRNAs, circRNAs, and lncRNAs (Figure 2A).
FIGURE 2

TDEs enhance the migration ability of tumor cells by promoting EMT and degrading the ECM. (A): Exosomes carry proteins, miRNA, lncRNA, and circRNA to promote the occurrence and development of EMT. (B): TDEs carry proteins or non-coding RNA to initiate degradation of the ECM.
Tumor-Derived Exosomes Promote Extracellular Matrix Degradation
The extracellular matrix (ECM) is a scaffold for tissues and organs (Eble and Niland, 2019). The ECM is a complex network combined with proteins, proteoglycans, and glycoproteins that can regulate cell growth, survival, motility, and differentiation through specific receptors, such as integrin, syndecan, and discoidin receptors (Leitinger, 2011; Xian et al., 2010). Cancer-associated ECM is not only an integral feature of a tumor but also actively contributes to its histopathology and malignant behavior (Levental et al., 2009; Provenzano et al., 2008). From tumor initiation to metastasis, ECM molecules bind with cell surface receptors and activate intracellular signaling pathways. ECM adhesion–induced signals promote self-sufficient growth through mitogen-activated protein kinase (MAPK) and phosphatidylinositol 3-kinase (PI3K) (Pylayeva et al., 2009). Focal adhesion kinase (FAK) signaling inhibits p15 and p21, which are growth suppressors, and p53 to limit the induction of apoptosis (Kim et al., 2008). TGF-β and RhoA/Rac signaling promote EMT induction and enhance promigratory pathways (Leight et al., 2012). The ECM can also enhance angiogenesis and strengthen vascular endothelial growth factor (VEGF) signaling in endothelial cells (Liu and Agarwal, 2010).
TDEs mediate tumor–tumor and tumor–host cell crosstalk (Kalluri, 2016). TDEs interact with and regulate the synthesis of ECM components and are involved in ECM remodeling (Rackov et al., 2018). The proteins on the surface of TDEs promote the activation of membrane-associated proteinases, such as Adamts1, Adamts4, and Adamts5, thus improving proteolytic activity (Ginestra et al., 1997; Lo Cicero et al., 2012). In addition, matrix metalloproteinases (MMPs) derived from TDEs participate in localized degradation and ECM proteolysis during cellular migration and metastasis (Ginestra et al., 1997; Atay et al., 2014). However, besides exosomal surface proteins, non-coding RNA also mediates ECM degradation. For example, breast cancer–derived exosomes carry miR-301 to regulate matrix modulation (Morad et al., 2020). Gastric cancer cell–derived exosomal miR-27a reshapes the ECM at adjacent sites and promotes tumor progression by downregulating CSRP2 expression and upregulating α-SMA expression (Wang et al., 2018). Currently, there are no direct reports on other non-coding RNAs, such as lncRNA and cicrRNA, but TDE-derived lncRNA and circRNA can influence fibroblast, chondrocyte, and epithelial cell function, secreting ECM components into the extracellular space (Tan et al., 2020).
Some data suggested that the ECM is a prerequisite for tumor cell invasion and metastasis (Tan et al., 2020). When the tumor cells metastasize, they detach from the ECM. Furthermore, the exosomes participate in this process (Figure 2B).
Tumor-Derived Exosomes Promote Angiogenesis Directly or Indirectly
Regardless of tumor size, metastasis may occur; however, in most cases, metastasis is associated with large primary neoplasms (Fidler and Kripke, 2015). If a tumor mass exceeds 1 mm in diameter, angiogenesis is bound to occur (Folkman, 1971; Nagy and Dvorak, 2012). Therefore, exploring tumor angiogenesis is an important way to understand tumor metastasis.
Tumor-Derived Exosomes Promote Angiogenesis by Activating Macrophages
Cancer-derived exosomes stimulate macrophage infiltration and polarization for establishing a pre-metastatic niche. For example, exosomes derived from CT-26, a colon cancer cell, can provoke macrophages to secrete significantly high levels of monocyte chemoattractant protein-1 (MCP-1) and TNF, thus promoting the growth and migration of colorectal cancer cells. Lung cancer cell–derived exosomes containing miRNA-103 upregulate angiogenic VEGF-A and angiopoietin-1 expression from M2 macrophages (Hsu et al., 2018; Wu et al., 2019). Therefore, TDEs can motivate the angiogenic property of macrophages such as secretion of VEGF (Wu et al., 2019). It can induce angiogenesis by tumor cells. In addition, other immune cells also contribute to tumor angiogenesis, such as neutrophils, myeloid precursor cells (MPCs), and dendritic cells (DCs) (Albini et al., 2018). But, there are no reports about TDE-educated neutrophils, MPCs, or DCs to promote angiogenesis in metastasis.
Tumor-Derived Exosomes Carry Non-coding RNA and Proteins to Promote Angiogenesis Directly
TDEs carry non-coding RNAs, including microRNA, lncRNA, and circRNA, that play an indispensable role in angiogenesis. TDEs carry miR-25-3p that regulates VEGFR2, ZO-1, occludin, and claudin5 expression in ECs by targeting KLF2 and KLF4 and eventually promotes vascular permeability and angiogenesis (Felcht et al., 2012; Wu et al., 2019). TDEs deliver miR-130a to vascular cells to promote angiogenesis by targeting c-MYB (Yang et al., 2018). Exosomal miR-155-5p can induce angiogenesis through the SOCS1/JAK2/STAT3 signaling pathway (Zhou X. et al., 2018). Exosomal miR-135b promotes angiogenesis by inhibiting FOXO1 expression. Exosomal miR-23a induces angiogenesis by targeting TSGA10, prolyl hydroxylase, tight junction protein ZO-1, and SIRT1 (Sruthi et al., 2018; Bai et al., 2019). Exosomal miR-1229 promotes angiogenesis by targeting HIPK2. Exosomal miR-21 promotes angiogenesis by targeting STAT3 (Liu and Cao et al., 2016). In addition, lncRNA containing lncCCAT2, lncMALAT1, lncRNA-p21, and lncPOU3F3 or circRNA, such as TDE-derived circRNA-100338, also promote angiogenesis (Castellano et al., 2020; Huang X.-Y. et al., 2020; Lang, Hu, & Chen et al., 2017; Lang, Hu, &; Zhang Z. et al., 2017; Qiu J.-J. et al., 2018). LncRNA and circRNA are often used as “sponges” to regulate miRNA expression in cells. Moreover, TDEs carry a variety of angiogenic proteins, such as VEGF, IGFBP3, MMP2, ICAM-1, and IL-8, thus enhancing angiogenesis through in vitro and in vivo ligand/receptor signaling (Ludwig and Whiteside, 2018). Therefore, a combination of multiple non-coding RNAs and exosomal proteins promotes tumor angiogenesis.
The importance of angiogenesis in tumor metastasis cannot be understated, TDEs can carry proteins and non-coding RNAs that directly promote angiogenesis or they can mediate angiogenesis indirectly by “educating” macrophages to release proangiogenic factors (Figure 3).
FIGURE 3

Exosomes directly or indirectly promote angiogenesis. TDEs promote macrophages to release TNF and VEGF to promote angiogenesis factors by carrying miRNAs or proteins. In addition, TDEs carry proteins, miRNAs, lncRNA, or circRNA to promote angiogenesis directly by targeting endothelial cells.
Tumor-Derived Exosomes can Protect Tumor Cells During Metastasis
Tumor cells shed from primary or secondary tumors are called circulating tumor cells (CTCs) (Paoletti and Hayes, 2016). CTCs invade the bloodstream and attach to the endothelium in the target organ. They then invade the surrounding parenchyma to form new tumors (Garcia et al., 2018). Blood is an unfavorable environment for CTCs, and they struggle with circulating immune cells (Agarwal et al., 2018). TDEs help CTCs metastasize smoothly by inhibiting immune cell activity and conferring a protective layer on them, thus maintaining cellular integrity (Figure 4).
FIGURE 4

Role of TDEs in protecting CTCs. TDEs from CTCs and activated platelets suppress NK cell, T cell, and B cell function. In addition, activated platelets can form thrombi that adhere to the surface to protect CTCs.
Tumor-Derived Exosomes can Suppress Immune Cells to Protect CTCs
The immune system inhibits the progression of cancer cells. Many immune cells are found circulating in human blood, including T lymphocytes, natural killer (NK) cells, and B lymphocytes (de la Cruz-Merino et al., 2008; Grivennikov et al., 2010; McCarthy, 2001). These immune cells play crucial roles in immune surveillance, immunosuppression, and killing effects and mainly act on CTCs (Deepak and Acharya, 2010; Pahl and Cerwenka, 2017; Wernersson and Pejler, 2014; Ye et al., 2017). Immune cells can recognize and attack CTCs under normal circumstances; therefore, immunosuppression is necessary for the metastasis of CTCs (Guo et al., 2019). Many researchers have found that TDEs can suppress immune cells. Exosomes carry bioactive molecules that can impair immune cell function (Becker et al., 2016; Kalluri, 2016; Robbins and Morelli, 2014). Programmed cell death receptor ligand 1 (PD-L1) can bind to programmed cell death protein 1 (PD-1) to inactivate T cells through its extracellular domain (L. Chen and Han, 2015; Chen et al., 2015; Garcia-Diaz et al., 2019). TDEs carry PD-L1 on their surface and suppress CD8+ T cell function in metastatic melanoma (Chen et al., 2018). In addition to PD-1, TDEs can also carry others to inhibit T cell function, and prolyl hydroxylase can inhibit CD4+ and CD8+ T cell functions by oxygen sensing (Clever et al., 2016). TDEs block T cell activation and enhance T cell apoptosis (Czernek and Dutchler, 2017; Ludwig et al., 2017). TDEs can also cause NK cell dysfunction. NK cells do not express PD-1; however, TDEs interfere with the TGFβ/TGFβRI/II pathway and other common molecular pathways, such as the adenosine pathway, eventually driving NK cell responses (Hong et al., 2017). In addition, TDEs can inhibit NK cell cytotoxicity by suppressing STAT5 activation (Zhang et al., 2007). B cells play a critical role in immunoglobulin, antigen, and proinflammatory cytokine secretion (Mauri and Bosma, 2012). TDE HMGB1 regulates the proliferation of T cell Ig and mucin domain-1+ (TIM-1+) B cells and fosters cancer cell immune evasion (Ye et al., 2018). We can design therapeutic modalities to enhance immune cell surveillance and killing of these tumors by understanding these signaling pathways.
CTCs Activate Platelets Directly or by Releasing Exosomes
Platelets play major roles in hemostasis and coagulation and regulate the efficiency of canceration, tumor angiogenesis, tumor metastasis, and chemotherapy (Sharma et al., 2014). Platelets and cancer cells interact, thus affecting tumor growth and metastasis (Sharma P. et al., 2018). During blood circulation, other nontumor help is essential, for example, platelets can protect CTCs from blood flow shear forces by providing a protective layer. CTCs release soluble mediators, such as adenosine diphosphate (ADP), thromboxane (TX) A2, or high-mobility group box 1 (HMGB1), that can ligate toll-like receptor 4 (TLR4) to instigate localized platelet activation and form thrombus encasing tumor cells, thus protecting them from cytolysis by NK cells (Aitokallio-Tallberg et al., 1985; Nieswandt et al., 1999; Yu et al., 2014; Zucchella et al., 1989).
The interaction between platelets and CTCs can lead to platelet activation, and platelets release cytokines conducive to the survival and proliferation of tumor cells. When platelets combine with circulating tumor cells, platelet-derived soluble factors (TGF β and PDGF) mediate and prevent NK cells from detecting and dissolving tumor cells (Lambert et al., 2017; Lee J.-K. et al., 2013).
Finally, platelets prevent tumor cells from being eliminated by the immune system. Platelet-derived TGF-β can downregulate NKG2D expression and inactivate NK cells (Y. Chen et al., 2015; Kopp et al., 2009). The platelet expression profile in tumor and nontumor patients varies substantially (Santarpia et al., 2018). The interaction between CTCs and platelets can protect CTCs from immune surveillance during circulation and help tumor cells adhere to the endothelial cells at the metastasis site (Santarpia et al., 2018). Kuznetsov et al. showed that luminal breast cancer cells carried platelets that loaded factors with the effect of pro-inflammatory and pro-angiogenic activities and confirmed that these factors were released at distant tumors sites (Kuznetsov et al., 2012). Platelets are essential for releasing proangiogenic cytokines and recruiting angiogenic vascular endothelial growth factor receptor 2+ (VEGFR2+) cells that promote malignant progression (Schlesinger, 2018). Moreover, studies have shown that platelets may not just have a secondary role but may also drive malignant progression (or metastasis) (Kuo et al., 2011).
In human blood, platelets are considered to be the major contributors of exosomes (Caby et al., 2005). Goetzl et al. showed that endothelial cells absorb platelet-derived exosomes and enhance their adhesion by increasing endothelial cell adhesion protein expression and anti-adhesion factor production, thereby promoting CTC adhesion in vascular endothelial cells (Goetzl et al., 2016). Platelet-derived exosomes also increase platelet adhesion to monocytes and consequently monocyte activation, thus promoting the formation of inflammatory phenotypes (Goetzl et al., 2016).
Therefore, many researchers believe that blood platelets may be a potential source of biomarkers to aid cancer diagnosis. Nonetheless, the mechanism using which CTC-educated platelets mediate CTCs to avoid damage in the circulatory system still needs further research. We firmly believe that these CTC-educated platelet-derived exosomes play an important role in preventing damage to CTCs.
Integrins of Tumor-Derived Exosomes Determine Organotropic Metastasis
That different types of cancer cells preferentially colonize and metastasize to different organs is the salient feature of metastasis (Nguyen et al., 2009). Current research shows that tumors mainly metastasize to lung, brain, lymph node, bone, and liver tissues. We have summarized organotropic metastasis with respect to cancer types (Table 1). Many studies focus on tumor cell adhesion function, and extracellular matrix molecules, such as integrins, have been determined to be related to the choice of organotropic metastasis (Valastyan and Weinberg, 2011).
TABLE 1
Chart for organotropic metastasis with respect to cancer types.
Integrins, a large family of adhesion molecules, can mediate cell–cell and cell–extracellular matrix interactions (Desgrosellier and Cheresh, 2010). Many integrins are associated with tumor angiogenesis, such as αvβ3, αvβ5, and α5β1 (Cascone et al., 2005; Lee et al., 2013a; Huang and Rofstad, 2018). β1 integrins bind to vascular cell adhesion molecule 1 (VCAM-1) on ECs and play an important role in trans-endothelial migration (Klemke et al., 2007). Integrins participate in tumor angiogenesis by interacting with the VEGF–VEGFR and ANG–TIE pathways (Klemke et al., 2007). αvβ3 integrin binds to the adhesion molecule L1 on ECs driving trans-endothelial migration (Voura et al., 2001). αvβ3 integrin is the most abundant and influential receptor among integrins on ECs and can regulate angiogenesis (De et al., 2005; Mahabeleshwar et al., 2008; Shattil and Ginsberg, 1997). It can be activated and colocalized with VEGFR-2 on ECs of proliferating blood vessels (Mahabeleshwar et al., 2008). VEGF-stimulated c-Src can be the phosphorylate β3 subunit on ECs, promoting VEGFR-2 phosphorylation and activation (De et al., 2005; Mahabeleshwar et al., 2008; Mahabeleshwar et al., 2007). In addition, αvβ3 is necessary for the survival and maturation of new blood vessels, and proliferative angiogenic EC apoptosis occurs after treatment with αvβ3 antagonists (Brooks et al., 1994). Briefly, integrin subunits α1, α2, α3, α4, α5, α6, α9, αv, β1, β3, and β5 are involved in physiological or pathological angiogenesis. Exosomes affect several steps of angiogenesis including motility, cytokine production, cell adhesion, and cell signaling (Taverna et al., 2012). These can improve the tumor survival environment before metastasis.
Although integrins are secreted by tumor cells, it is transported by exosomes to a distant organ (Peinado et al., 2017). Lyden et al. showed that tumor exosome integrins can determine organotropic metastasis. They suggested that tumor exosome integrins can fuse with organ-specific resident cells and activate Src phosphorylation and proinflammatory S100 expression to establish a pre-metastatic niche (Hoshino et al., 2015). In addition, more bodies of evidence identified that different integrins on the surface of exosomes play varied roles in metastasis to specific organs (Alderton, 2015; Hoshino et al., 2015; Paolillo and Schinelli, 2017). For instance, exosomal integrins α6β4 and α6β1 preferentially direct tumor cells to the lungs, and αvβ5 induces liver metastasis (Hoshino et al., 2015). Tumor exosomes can prepare pre-metastatic niches to facilitate organ-specific metastasis, even for cancer cells equipped to metastasize (Figure 5).
FIGURE 5

Choice of metastatic organs. The integrin on the surface of the exosome determines where the tumor metastasizes.
Tumor Cell Growth at the Metastasis Site
Once tumor cells migrate to tissues and organs, TDEs provide them with a good growth environment and the ability to promote their growth.
Tumor-Derived Exosomes Promote Pre-metastatic Niche Formation
A pre-metastasis niche is a primary tumor in secondary organs and tissues that creates a favorable microenvironment for subsequent metastasis. Tumor-derived molecules secreted by primary tumors play a key role in preparing distant sites for the formation of new pre-metastasis niches, promoting metastasis and even determining the orientation of metastatic organs. These major tumor-derived molecules are usually tumor-derived secretory factors, extracellular vesicles (EVs), and other molecular components (Minciacchi et al., 2015). Exosomes containing protein, mRNA, or DNA fragments promote the pre-metastasis niche formation by mediating the communication between tumor cells and surrounding components or transferring their contents to recipient cells (Chin and Wang, 2016; Zhou et al., 2014).
Tumor cells are “seeds”. With tumor-secreting factors, tumor cell–secreting vesicles, and exosomes acting as catalysts, tumor cells can promote the formation of the “soil” (host microenvironment) in a distant metastasis site and promote the growth of cancer cells. Cancer metastasis is preceded by the interaction between the seed and soil (Y. Chen et al., 2015; Lambert et al., 2017; Liu and Cao, 2016; Minciacchi et al., 2015). Primary tumor cells influence and change the microenvironment at secondary organs by promoting pre-metastasis niche factor before tumor cells arrive (Chin and Wang, 2016; He et al., 2017).
The characteristics of a pre-metastasis niche include the following six aspects. First, pre-metastasis niche formation is accompanied by the recruitment of bone marrow–derived cells (BMDC) (Y. Chen et al., 2015; Minciacchi et al., 2015). Literature suggests that extracellular matrix metalloproteinase inducer (EMMPRIN) in cancer cells can induce the secretion and expression of many factors, such as SDF and VEGF, which mediate the recruitment of BMDC to the liver and lungs (Y. Chen et al., 2015; Minciacchi et al., 2015). Second, the immune cells involved in the pre-transfer niche formation are heterogenous. Pre-metastasis niche formation involves not only the recruitment of foreign cells but also the reprogramming of resident stromal cells, promoting metastasis. Pre-metastasis niche formation also involves the change of the ECM. Niche formation before transfer is accompanied by a change in the vascular system. Metastatic breast cancer cells reduce tight junctions between endothelial cells by secreting exosomes containing mir-105, thus inducing systemic vascular leakage and promoting metastasis (Kong et al., 2019). Breast cancer cells secrete exosomes containing miR-122, which are absorbed by niche cells, and reduce glucose consumption by targeting pyruvate kinase, thus increasing the proliferation rate and survival rate of cancer cells and promoting metastasis (Fong et al., 2015). Pancreatic cancer–derived exosomes, rich in macrophage migration inhibitory factors, recruit macrophages and induce pre-metastasis niche formation in the liver (Costa-Silva et al., 2015). Modulation of the pre-metastatic niche formation by controlling TDEs is a new area for future chemotherapy research.
Tumor-Derived Exosomes Promote the Growth of Metastasis Tumor
The growth of metastatic tumors requires suitable “soil”. MET returns the cancer cells to a highly proliferative state but with the loss of their migration characteristics, enabling tumor growth at the metastasis site (Li K. et al., 2019). The characteristics of MET are increased expression of mesenchymal markers, such as vimentin, and decreased expression of epithelial markers, such as E-cadherin, compared with that of EMT (Wells et al., 2008). MET supports the reacquisition of epithelial features to promote metastasis (Brabletz et al., 2001). Several signaling pathways are involved in regulating MET, including transforming growth factor (TGF), fibroblast growth factors (FGFs), bone morphogenic protein (BMP), epidermal growth factor receptor (EGFR), hepatocyte growth factor (HGF), Wnt/β-catenin, and Notch pathways (Said and Williams, 2011). TDEs can support tumor progression and remodel surrounding parenchymal tissues at the metastatic site (Greening et al., 2015). TDEs play an important regulatory role mediating EMT and transforming MET (Bigagli et al., 2019). Gastric cancer cell–derived exosomes can mediate the stimulation of proinflammatory cytokine IL-1β secretion and activate the Akt and MAPK pathways to promote tumor growth at the metastatic site (Che et al., 2018; Wang et al., 2019e). In addition, TDEs can transform stromal cells into tumor-associated stromal cells (TASCs) that can secrete many pro-tumorigenic factors, including IL-6 and IL-8. These factors can enhance the proliferation ability of tumor cells (Bussard et al., 2016). Hence, TDEs can enable tumor cells to acquire proliferation capacity directly through the MET process or promote tumor proliferation by inducing TASC formation and releasing related factors (Figure 6). Nevertheless, there is still a dearth of research on exosomes and their contribution to MET.
FIGURE 6

TDEs promote tumor growth at the metastasis site. MET and TASCs promote tumor growth at metastatic sites, and TDEs can derive MET and TASC formation.
Conclusion
Exosomes play an important role in every step leading to tumor metastasis. Although there are many reports on the role of exosomes in metastasis, much is left to be explored of the potential mechanisms underlying metastasis. Although a few studies still have unclear results, we have summarized the published literature on the substances that exosomes carry, their main functions in different tumors, the target cells affected, and steps involved in metastasis. (Table 2). Exploring these underlying mechanisms will enlighten us about cancer biology and contribute to the prevention of and therapeutic strategies for malignancies. We can manipulate TDEs to impede not just metastasis formation but even established metastases.
TABLE 2
| Cancer type | Exosome component | Target cells | Potential regulation | Roles in metastasis steps | References |
|---|---|---|---|---|---|
| AML | TGF-β | NK cells | NKG2D | Step 3: immunosuppressive | Szczepanski et al. (2011) |
| DPP4 | Bone | - | Step 5 | Namburi et al. (2021) | |
| TGFβ/TGFβRI/II | NK-92 | - | Step 3: immunosuppressive | Hong et al. (2017) | |
| Breast cancer | miR-10b | Mammary epithelial cells | HOXD10 and KLF4 | Step 1: enhance invasion ability | Singh et al. (2014) |
| miR-122 | Lung fibroblast neurons | PKM | Step 2: non-coding RNA influence angiogenesis | Fong et al. (2015) | |
| RN7SL1 | Breast cancer cells | PRR RIG-I | Step 5 | Nabet et al. (2017) | |
| miR-200c, miR-141 | Breast cancer cells | FOXP3-KAT2B | Enhance metastases | Zhang G. et al. (2017) | |
| miRNA-503 | Microglia | - | Step 3: immunosuppressive | Xing et al. (2018) | |
| Caveolin-1 | Breast cancer cells | - | Enhance metastases | Campos et al. (2018) | |
| miR-193b | Breast cancer cells | RAB22A | Step 1: enhance invasion ability | Sun et al. (2018) | |
| CEMIP | Brain endothelial and microglial cells | - | Step 2: angiogenesis | Rodrigues et al. (2019) | |
| hsa-miR-940 | Osteoblastic | ARHGAP1 and FAM134A | Step 5 | Hashimoto et al. (2018) | |
| miR-126a | Lung | S100A8/A9 | Step 2 | Deng et al. (2017) | |
| miR-222 | Breast cancer cells | NF-κB | Step 1 | Ding et al. (2018) | |
| miR-130a-3p | Breast cancer cells | RAB5B | Step 1 | Kong et al. (2018) | |
| miR-939 | Breast cancer cells | VE-cadherin | Step 2: non-coding RNA influence angiogenesis | Di Modica et al. (2017) | |
| miR-770 | TNBCs | STMN1 | Decrease metastases | Li Y. et al. (2018) | |
| miR-4443 | Breast cancer cells | TIMP2 | Step 4 | Wang H. et al. (2020) | |
| miR-210 | Endothelial cells | - | Step 2: non-coding RNA influence angiogenesis | Kosaka et al. (2013) | |
| miR-1910-3p | Breast cancer cells | MTMR3 | Step 1: enhance invasion ability | Wang B. et al. (2020) | |
| miR-146a | CAFs | TXNIP | Step 5 | Yang et al. (2020b) | |
| miR-4443 | Liver | - | Step 1: enhances invasion ability | Wang J. et al. (2020) | |
| Bladder Cancer | LINC02470, LINC00960 | Bladder cancer cells | - | Step 1: EMT | Huang et al. (2020b) |
| CML | miR-92a | EC | Integrin α5 | Step 2: non-coding RNA influence angiogenesis | Umezu et al. (2014) |
| Colon cancer | hsp 70 | MDSC | STAT3 | Step 3: immunosuppressive | Chalmin et al. (2010) |
| KRAS mutation | Colon CA cells | - | Step 5: tumor growth | Demory Beckler et al. (2013) | |
| TF | EC | - | Step 3: platelet activation | Garnier et al. (2012) | |
| miR-193a | Colon cancer cells | Caprin1 | Step 5: decrease the growth of cells | Teng et al. (2017) | |
| miR-92a-3p | Colon cancer cells | - | Step 1: EMT | Hu J. L. et al. (2019) | |
| lncRNA H19 | Colon cancer cells | miR-141 | Step 5: MET | Ren et al. (2018) | |
| miR-21-5p; miR-155-5p | Colon cancer cells | BRG1 | Step 5 | Lan et al. (2019) | |
| miR-182-3p | Colon cancer cells | FOXO4 | Step 1: EMT | Liu et al. (2019) | |
| GDF15 | HUVECs | Smad | Step 2 | Zheng et al. (2020) | |
| MCP-1; TNF | Macrophages | - | Step 2: activating macrophages | Chen et al. (2016) | |
| miR-25-3p | ECs | VEGFR, ZO-1, occludin, and claudin5 | Step 2: angiogenesis | Zeng et al. (2018) | |
| miR-1229 | ECs | HIPK2 | Step 2: angiogenesis | Hu H.-Y. et al. (2019) | |
| Cervical cancer | Survivin | Cervical cancer cells | - | Step 5: tumor growth | (Khan et al., 2009; Khan et al., 2011) |
| Cicr-PVT1 | Cervical cancer cells | MiR-1286 | Step 1: EMT | Wang H. et al. (2020) | |
| miR-221-3p | HLEC | VASH1 | Step 2: Lymphatic vessel formation | Zhou et al. (2019) | |
| miR-663b | Cervical cancer cells | MGAT3 | Step 1: EMT | You et al. (2021b) | |
| GIST | KIT | Progenitor muscle cells | MMP1 | Step 1: Influence the relationship between tumor cells and cell matrix | You et al. (2021b) |
| Gastric cancer | miR-27a | CAFs | - | Step 1: EMT | Wang J. et al. (2018) |
| miR-130a | ECs | C-MYB | Step 2: angiogenesis | Yang et al. (2018) | |
| miR-135b | ECs | FOX1 | Step 2: angiogenesis | Bai et al. (2019) | |
| Glioblastoma | EGFR vIII | Glioblastoma cells | VEGF, Bcl-x (L), p27 | Step 5: tumor growth | Al-Nedawi et al. (2008) |
| matrix metalloproteinases, IL-8, PDGFs, and caveolin 1 | Glioblastoma cells | PI3K/AKT | Step 1: EMT | Kucharzewska et al. (2013) | |
| L1CAM | Glioblastoma cells | FAK; FGFR | Enhance metastases | Pace et al. (2019) | |
| miR-148a | Glioblastoma cells | CADM1 | Step 1 | Cai et al. (2018) | |
| MDA-9/Syntenin | Glioblastoma cells | CD63-AP-2 | Step 1 | Das et al. (2018) | |
| LncRNA CCAT2 | ECs | - | Step 2: angiogenesis | Lang et al. (2017a) | |
| LncRNA POU3F3 | ECs | - | Step 2: angiogenesis | Lang et al. (2017b) | |
| HCC | miR-584, 517c, 378 | HCC cells | TAK1 | Step 5: tumor growth | Kogure et al. (2011) |
| miR-1247-3p | Fibroblasts | B4GALT3 | Step 5: TASCs | Fang T. et al. (2018) | |
| miR-122 | HCC cells | Step 5: tumor growth | Qian and Pollard, (2010) | ||
| miR-27b-3p/miR-92a-3p | HCC cells | IGF1R | Step 5: tumor growth | Basu and Bhattacharyya et al. (2014) | |
| miR-103 | ECs | VE-cadherin | Step 2: non-coding RNA influence angiogenesis | Basu and Bhattacharyya et al. (2014), Fang J. H. et al. (2018) | |
| miR-21, miR-10b | HCC cells | - | Step 1 | Tian et al. (2019) | |
| SMAD3 | HCC cells | ROS | Step 4: attach | Fu et al. (2018) | |
| Step 5: tumor growth | |||||
| LOXL4 | HUVECs | FAK/Src | Step 2: angiogenesis | Li R. et al. (2019) | |
| Vps4A | HCC cells | β-catenin | Step 1: EMT | Han et al. (2019) | |
| miR-320a | HCC cells | CDK2, MMP2 | Step 1: EMT | Zhang Z. et al. (2017) | |
| Step 5: TASCs | |||||
| lncRNA FAL1 | HCC cells | miR-1236 | Enhance metastases | Li B. et al. (2018) | |
| p120-catenin | HCC cells | STAT3 | Enhance metastases | Cheng et al. (2019) | |
| miR-372-3p | HCC cells | Rab11a | Enhance metastases | Cao et al. (2019) | |
| Alpha-enolase | HCC cells | Integrin α6β4 | Enhance metastases | Jiang et al. (2020) | |
| circ_MMP2 | HCC cells | MMP2 | Enhance metastases | Liu et al. (2020) | |
| miR-92a-3p | HCC cells | PTEN/Akt | Step 1: EMT | Liu et al. (2020) | |
| Linc00161 | HUVECs | miR-590-3p/ROCK | Step 2: angiogenesis | You et al. (2021a) | |
| miR-30a; miR-222 | HCC cells | MIA3 | Enhance metastases | Du et al. (2021) | |
| S100A4 | HCC cells | STAT3 | Enhance metastases | Sun et al. (2021) | |
| miR-1290 | ECs | SMEK1 | Step 2: angiogenesis | Wang et al. (2021b) | |
| circRNA-100338 | HUVECs | - | Step 2: angiogenesis | Huang et al. (2020b) | |
| TIM11 | B cells | TLR/MAPK | Step 3: immunosuppressive | Ye et al. (2018) | |
| HNC | FasL | T cells | Jurkat | Step 3: immunosuppressive | Kim et al. (2005) |
| miR-23a | HUVECs | TSGA10 | Step 2: angiogenesis | Bao et al. (2018) | |
| - | NK cells | NKG2D | Step 3: immunosuppressive | Ludwig et al. (2017) | |
| Lung Cancer | miR-103 | M2 macrophages | VEGF-A | Step 2: angiogenesis | (Hsu et al., 2018; Wu et al., 2019) |
| miR-23a | ECs | ZO-1 | Step 2: angiogenesis | Hsu et al. (2017) | |
| miR-21 | HUVECs | - | Step 2: angiogenesis | Liu et al. (2016a) | |
| LncRNA-p21 | HUVECs | - | Step 2: angiogenesis | Castellano et al. (2020) | |
| Melanoma | MET | BM progenitor cells | - | Step 5: tumor growth | Peinado et al. (2012) |
| PD-L1 | T cells | PD-1 | Step 3: immunosuppressive | Chen et al. (2018) | |
| snRNA | Lung epithelial cells | TLR3 | Step 5: TASCs | Liu et al. (2016b) | |
| CD151 | Lung, lymph node and stromal cells | - | Step 4: location | Malla et al. (2018) | |
| Fas | T cells | MMP9 | Step 3: immunosuppressive | Cai et al. (2012) | |
| miR-191; let-7a | Melanoma cells | - | Step 1: EMT | Xiao et al. (2016) | |
| Immunomodulatory, proangiogenic factors | Melanoma cells | - | Step 2: angiogenesis | Ekstrom et al. (2014) | |
| Step 3: immunosuppressive | |||||
| HSP70 | NK cells | - | Step 3: immunosuppressive | Elsner et al. (2007) | |
| uPAR | HMVECs; ECFCs | ERK1,2 | Step 2: angiogenesis | Biagioni et al. (2021) | |
| miR-106b-5p | Melanoma cells | EphA4 | Step 5: MET | Luan et al. (2021) | |
| miR-155-5p | CAFs | SOCS1/JAK2/STAT3 | Step 2: angiogenesis | Zhou X. et al. (2018) | |
| Multiple myeloma (BM-MSC) | miR-15a | MM cells | FAK | Step 1: enhance invasion ability | Roccaro et al. (2013) |
| miR-let-7c | ECs | - | Step 2: TDEs promote angiogenesis by activating macrophages | Tian et al. (2021) | |
| miR-135b | EC | HIF-FIH | Step 2 | Umezu et al. (2014) | |
| Mesothelioma | TGF-β | Fibroblasts | SMAD | Step 1: influence the relationship between tumor cells and cell matrix | Webber et al. (2010) |
| NPC | HIF1α | NPC cells | LMP1 | Step 1 | Aga et al. (2014) |
| miR-23a | EC | TSGA10 | Step 2: angiogenesis | Bao et al. (2018) | |
| MMP13 | NPC cells | - | Step 1 | You et al. (2015) | |
| Step 2: angiogenesis | |||||
| circMYC | NPC cells | - | Enhance metastases | Luo et al. (2020a) | |
| LMP1 | NPC cells | - | Step 1: EMT | Aga et al. (2014) | |
| Ovarian cancer | FasL | T cells | CD3-zeta | Step 3: immunosuppressive | Taylor et al. (2003) |
| ATF2; MTA1; ROCK1/2 | HUVECs | - | Step 2: angiogenesis | Yi et al. (2015) | |
| GNA12; EPHA2; COIA1 | MSCs; ECs | - | Step 5 | Sharma et al. (2018b) | |
| CD44 | HPMCs | - | Step 1 | Nakamura et al. (2017a) | |
| circWHSC1 | HPMCs | miR-145; miR-1182 | Step 2 | Nakamura et al. (2017b); Zong et al. (2019) | |
| miR-375 | Ovarian cancer cells | CA-125 | Enhance metastases | Su et al. (2019) | |
| miR-7 | EOC | EGFR, AKT, ERK1/2 | Decrease metastases | Hu et al. (2017) | |
| LncRNA FAL1 | Ovarian cancer cells | PTEN/AKT | Enhance metastases | Hu et al. (2017) | |
| miR-6780b-5p | Ovarian cancer cells | - | Step 1: EMT | Cai et al. (2021) | |
| circRNA051239 | Ovarian cancer cells | - | Step 5 | Ma R. et al. (2021) | |
| LncRNA MALAT1 | HUVECs | - | Step 2: angiogenesis | Qiu et al. (2018a) | |
| Pancreatic cancer | MIF | Liver Kupfer cells | - | Step 5: tumor growth | Costa-Silva et al. (2015) |
| miR-301a-3p | Macrophages | PTEN/PI3Kγ | Step 2: active macrophages | Wang X. et al. (2018) | |
| circ-IARS | HUVECs | - | Enhance metastases | Li J. et al. (2018) | |
| Lin28B | CAFs | let-7, HMGA2, PDGFB | Step 5 | Zhang et al. (2019c) | |
| miR-501-3p | Pancreatic ductal adenocarcinoma | TGFBR3, TGF-β | Enhance metastases | Yin et al. (2019) | |
| lncRNA Sox2ot | Pancreatic ductal adenocarcinoma | - | Step 1: EMT | Li Z. et al. (2018) | |
| CD151, Tspan8 | ASML | - | Step 1: matrix degradation | Yue et al. (2015) | |
| miR92a-3p | Pancreatic ductal adenocarcinoma | PTEN/Akt | Step 1: EMT | Yang et al. (2020a) | |
| CD44v6/C1QBP | Pancreatic ductal adenocarcinoma | - | Step 5 | Xie et al. (2021) | |
| Prostate cancer | αvβ6 Integrin | Prostate cancer cells | - | Step 4 | Lazaro-Ibanez et al. (2014) |
| miR-1246 | Prostate cancer cells | N-cadherin; vimentin | Step 1: EMT | Bhagirath et al. (2018) | |
| miR-940 | Osteoblastic | ARHGAP1, FAM134A | Enhance metastases | Bhagirath et al. (2018) | |
| miR-26a | Prostate cancer cells | - | Step 1: EMT | Wang et al. (2019f) | |
| PKM2 | BMSCs | CXCL12 | Step 5 | Dai et al. (2019) | |
| PSGR | Prostate cancer cells | - | Step 1: EMT | Li et al. (2021) | |
| TGF-β2, TNF1α, IL6, TSG101, Akt, ILK, β-catenin | Prostate cancer cells | - | Step 1: matrix degradation | Ramteke et al. (2015) |
Role and target of the components of TDEs in tumor metastasis.
The role of exosomes in various cancer metastases. AML: acute myeloid leukemia. CML: chronic myeloid leukemia. GIST: gastrointestinal stromal tumor. HCC: hepatocellular carcinoma. HNC: head and neck cancer. NPC: nasopharyngeal carcinoma.
Statements
Author contributions
SB and ZW developed the first draft of the manuscript. All authors contributed to the planning, organization, data collection, and writing of the manuscript. JD completed all figures and provided critical edits. The final version of the manuscript was approved by all authors.
Funding
The study was supported by grants from the National Natural Science Foundation of China (Grant Nos. 81972539 and U1732157).
Conflict of interest
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors, and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
References
1
Abdel RahmanA. R. M.GaafarR. M.BakiH. A.El HosienyH. M.AboulkasemF.FarahatE. G.et al (2008). Prevalence and Pattern of Lymph Node Metastasis in Malignant Pleural Mesothelioma. Ann. Thorac. Surg.86 (2), 391–395. 10.1016/j.athoracsur.2008.04.012
2
AbeY.SuzukiM.TsujiK.SatoM.KimuraH.KimuraH.et al (2020). Lung Metastasis from Gastric Cancer Presenting as Diffuse Ground-Glass Opacities. Respir. Med. Case Rep.30, 101104. 10.1016/j.rmcr.2020.101104
3
AgaM.BentzG. L.RaffaS.TorrisiM. R.KondoS.WakisakaN.et al (2014). Exosomal HIF1α Supports Invasive Potential of Nasopharyngeal Carcinoma-Associated LMP1-Positive Exosomes. Oncogene33 (37), 4613–4622. 10.1038/onc.2014.66
4
AgarwalA.BalicM.El-AshryD.CoteR. J. (2018). Circulating Tumor Cells. Cancer J.24 (2), 70–77. 10.1097/PPO.0000000000000310
5
AiC.MaG.DengY.ZhengQ.GenY.LiW.et al (2020). Nm23‐H1 Inhibits Lung Cancer Bone‐specific Metastasis by Upregulating miR‐660‐5p Targeted SMARCA5. Thorac. Cancer11 (3), 640–650. 10.1111/1759-7714.13308
6
Aitokallio-TallbergA.KärkkäinenJ.PantzarP.WahlströmT.YlikorkalaO. (1985). Prostacyclin and Thromboxane in Breast Cancer: Relationship between Steroid Receptor Status and Medroxyprogesterone Acetate. Br. J. Cancer51 (5), 671–674. 10.1038/bjc.1985.101
7
AktanM.KocM.YavuzB. B.KanyilmazG. (2015). Two Cases of Gastrointestinal Stromal Tumor of the Small Intestine with Liver and Bone Metastasis. Ann. Transl Med.3 (17), 259. 10.3978/j.issn.2305-5839.2015.09.46
8
Al-NedawiK.MeehanB.MicallefJ.LhotakV.MayL.GuhaA.et al (2008). Intercellular Transfer of the Oncogenic Receptor EGFRvIII by Microvesicles Derived from Tumour Cells. Nat. Cel Biol10 (5), 619–624. 10.1038/ncb1725
9
AlbiniA.BrunoA.NoonanD. M.MortaraL. (2018). Contribution to Tumor Angiogenesis from Innate Immune Cells within the Tumor Microenvironment: Implications for Immunotherapy. Front. Immunol.9, 527. 10.3389/fimmu.2018.00527
10
AldertonG. K. (2015). Directions to Metastatic Sites. Nat. Rev. Cancer15 (12), 696–697. 10.1038/nrc4046
11
AlhoulaibyS.AbdulrahmanA.AlouniG.MahfoudM.ShihabiZ. (2020). Extra‐CNS Metastasis of Glioblastoma Multiforme to Cervical Lymph Nodes and Parotid Gland: A Case Report. Clin. Case Rep.8 (9), 1672–1677. 10.1002/ccr3.2985
12
AliA.KimS. H.KimM. J.ChoiM. Y.KangS. S.ChoG. J.et al (2017). O-GlcNAcylation of NF-kappaB Promotes Lung Metastasis of Cervical Cancer Cells via Upregulation of CXCR4 Expression. Mol. Cell40 (7), 476–484. 10.14348/molcells.2017.2309
13
AljohaniH. M.AittalebM.FurgasonJ. M.AmayaP.DeebA.ChalmersJ. J.et al (2018). Genetic Mutations Associated with Lung Cancer Metastasis to the Brain. Mutagenesis33 (2), 137–145. 10.1093/mutage/gey003
14
AlShammariA.AlmasriT.SarrajJ.AlAshgarO.AhmedM. H.AlKattanK.et al (2020). Pulmonary Metastasis of Head and Neck Cancer: Surgical Removal Outcomes from a Tertiary Care center. Indian J. Thorac. Cardiovasc. Surg.36 (3), 199–206. 10.1007/s12055-019-00866-3
15
AsohY.NakamuraM.MaedaT.ShiogaiT.OgashiwaM.TakeuchiK.et al (1990). Brain Metastasis from Primary Pericardial Mesothelioma. Neurol. Med. Chir.(Tokyo)30 (11 Spec No), 884–887. 10.2176/nmc.30.884
16
AtayS.BanskotaS.CrowJ.SethiG.RinkL.GodwinA. K. (2014). Oncogenic KIT-Containing Exosomes Increase Gastrointestinal Stromal Tumor Cell Invasion. Proc. Natl. Acad. Sci.111 (2), 711–716. 10.1073/pnas.1310501111
17
BaiM.LiJ.YangH.ZhangH.ZhouZ.DengT.et al (2019). miR-135b Delivered by Gastric Tumor Exosomes Inhibits FOXO1 Expression in Endothelial Cells and Promotes Angiogenesis. Mol. Ther.27 (10), 1772–1783. 10.1016/j.ymthe.2019.06.018
18
BakirB.ChiarellaA. M.PitarresiJ. R.RustgiA. K. (2020). EMT, MET, Plasticity, and Tumor Metastasis. Trends Cel Biol.30 (10), 764–776. 10.1016/j.tcb.2020.07.003
19
BalajL.LessardR.DaiL.ChoY.-J.PomeroyS. L.BreakefieldX. O.et al (2011). Tumour Microvesicles Contain Retrotransposon Elements and Amplified Oncogene Sequences. Nat. Commun.2, 180. 10.1038/ncomms1180
20
BaleR.PutzerD.SchullianP. (2019). Local Treatment of Breast Cancer Liver Metastasis. Cancers11 (9), 1341. 10.3390/cancers11091341
21
BaoL.YouB.ShiS.ShanY.ZhangQ.YueH.et al (2018). Metastasis-associated miR-23a from Nasopharyngeal Carcinoma-Derived Exosomes Mediates Angiogenesis by Repressing a Novel Target Gene TSGA10. Oncogene37 (21), 2873–2889. 10.1038/s41388-018-0183-6
22
BasuS.BhattacharyyaS. N. (2014). Insulin-like Growth Factor-1 Prevents miR-122 Production in Neighbouring Cells to Curtail its Intercellular Transfer to Ensure Proliferation of Human Hepatoma Cells. Nucleic Acids Res.42 (11), 7170–7185. 10.1093/nar/gku346
23
BeckerA.ThakurB. K.WeissJ. M.KimH. S.PeinadoH.LydenD. (2016). Extracellular Vesicles in Cancer: Cell-To-Cell Mediators of Metastasis. Cancer Cell30 (6), 836–848. 10.1016/j.ccell.2016.10.009
24
BerishR. B.AliA. N.TelmerP. G.RonaldJ. A.LeongH. S. (2018). Translational Models of Prostate Cancer Bone Metastasis. Nat. Rev. Urol.15 (7), 403–421. 10.1038/s41585-018-0020-2
25
BhagirathD.YangT. L.BucayN.SekhonK.MajidS.ShahryariV.et al (2018). microRNA-1246 Is an Exosomal Biomarker for Aggressive Prostate Cancer. Cancer Res.78 (7), 1833–1844. 10.1158/0008-5472.CAN-17-2069
26
BhandariV.JainR. (2013). A Retrospective Study of Incidence of Bone Metastasis in Head and Neck Cancer. J. Can. Res. Ther.9 (1), 90–93. 10.4103/0973-1482.110385
27
BiagioniA.LaurenzanaA.MenicacciB.PeppicelliS.AndreucciE.BianchiniF.et al (2021). uPAR-Expressing Melanoma Exosomes Promote Angiogenesis by VE-Cadherin, EGFR and uPAR Overexpression and Rise of ERK1,2 Signaling in Endothelial Cells. Cell. Mol. Life Sci.78 (6), 3057–3072. 10.1007/s00018-020-03707-4
28
BigagliE.CinciL.D'AmbrosioM.LuceriC. (2019). Transcriptomic Characterization, Chemosensitivity and Regulatory Effects of Exosomes in Spontaneous EMT/MET Transitions of Breast Cancer Cells. Cancer Genomics Proteomics16 (3), 163–173. 10.21873/cgp.20122
29
BrabletzT.JungA.ReuS.PorznerM.HlubekF.Kunz-SchughartL. A.et al (2001). Variable -catenin Expression in Colorectal Cancers Indicates Tumor Progression Driven by the Tumor Environment. Proc. Natl. Acad. Sci.98 (18), 10356–10361. 10.1073/pnas.171610498
30
BrooksP. C.MontgomeryA. M. P.RosenfeldM.ReisfeldR. A.HuT.KlierG.et al (1994). Integrin αvβ3 Antagonists Promote Tumor Regression by Inducing Apoptosis of Angiogenic Blood Vessels. Cell79 (7), 1157–1164. 10.1016/0092-8674(94)90007-8
31
BussardK. M.MutkusL.StumpfK.Gomez-ManzanoC.MariniF. C. (2016). Tumor-associated Stromal Cells as Key Contributors to the Tumor Microenvironment. Breast Cancer Res.18 (1), 84. 10.1186/s13058-016-0740-2
32
BustamanteP.PiquetL.LandrevilleS.BurnierJ. V. (2021). Uveal Melanoma Pathobiology: Metastasis to the Liver. Semin. Cancer Biol.71, 65–85. 10.1016/j.semcancer.2020.05.003
33
CabyM.-P.LankarD.Vincendeau-ScherrerC.RaposoG.BonnerotC. (2005). Exosomal-like Vesicles Are Present in Human Blood Plasma. Int. Immunol.17 (7), 879–887. 10.1093/intimm/dxh267
34
CaiJ.GongL.LiG.GuoJ.YiX.WangZ. (2021). Exosomes in Ovarian Cancer Ascites Promote Epithelial-Mesenchymal Transition of Ovarian Cancer Cells by Delivery of miR-6780b-5p. Cell Death Dis12 (2), 210. 10.1038/s41419-021-03490-5
35
CaiQ.ZhuA.GongL. (2018). Exosomes of Glioma Cells Deliver miR-148a to Promote Proliferation and Metastasis of Glioblastoma via Targeting CADM1. Bull. du Cancer105 (7-8), 643–651. 10.1016/j.bulcan.2018.05.003
36
CaiZ.YangF.YuL.YuZ.JiangL.WangQ.et al (2012). Activated T Cell Exosomes Promote Tumor Invasion via Fas Signaling Pathway. J.I.188 (12), 5954–5961. 10.4049/jimmunol.1103466
37
CaldariaA.GiuffridaR.di MeoN.MassariL.DianzaniC.CannavòS. P.et al (2020). Diagnosis and Treatment of Melanoma Bone Metastasis: A Multidisciplinary Approach. Dermatol. Ther.33 (6), e14193. 10.1111/dth.14193
38
CamposA.SalomonC.BustosR.DíazJ.MartínezS.SilvaV.et al (2018). Caveolin-1-containing Extracellular Vesicles Transport Adhesion Proteins and Promote Malignancy in Breast Cancer Cell Lines. Nanomedicine13 (20), 2597–2609. 10.2217/nnm-2018-0094
39
CandaA. E.OzsoyY.NalbantO. A.SagolO. (2008). Gastrointestinal Stromal Tumor of the Stomach with Lymph Node Metastasis. World J. Surg. Onc6, 97. 10.1186/1477-7819-6-97
40
CaoS.-Q.ZhengH.SunB.-C.WangZ.-L.LiuT.GuoD.-H.et al (2019). Long Non-coding RNA Highly Up-Regulated in Liver Cancer Promotes Exosome Secretion. Wjg25 (35), 5283–5299. 10.3748/wjg.v25.i35.5283
41
CarvalhoJ.TeixeiraM.SilvaF. T.EstevesA.RibeiroC.GuerraD. (2020). Esophageal Gastrointestinal Stromal Tumor with Rare Intracranial Metastasis. Case Rep. Gastrointest. Med.2020, 1–4. 10.1155/2020/8842006
42
CasconeI.NapioneL.ManieroF.SeriniG.BussolinoF. (2005). Stable Interaction between α5β1 Integrin and Tie2 Tyrosine Kinase Receptor Regulates Endothelial Cell Response to Ang-1. J. Cel Biol170 (6), 993–1004. 10.1083/jcb.200507082
43
CastellanoJ. J.MarradesR. M.MolinsL.ViñolasN.MoisesJ.CanalsJ.et al (2020). Extracellular Vesicle lincRNA-P21 Expression in Tumor-Draining Pulmonary Vein Defines Prognosis in NSCLC and Modulates Endothelial Cell Behavior. Cancers12 (3), 734. 10.3390/cancers12030734
44
CavannaL.SeghiniP.Di NunzioC.OrlandiE.MichielettiE.StroppaE.et al (2018). Gastric Cancer with Brain Metastasis and the Role of Human Epidermal Growth Factor 2 Status. Oncol. Lett.15 (4), 5787–5791. 10.3892/ol.2018.8054
45
ChalminF.LadoireS.MignotG.VincentJ.BruchardM.Remy-MartinJ.-P.et al (2010). Membrane-associated Hsp72 from Tumor-Derived Exosomes Mediates STAT3-dependent Immunosuppressive Function of Mouse and Human Myeloid-Derived Suppressor Cells. J. Clin. Invest.120 (2), 457–471. 10.1172/JCI40483
46
ChangG.ShiL.YeY.ShiH.ZengL.TiwaryS.et al (2020). YTHDF3 Induces the Translation of m6A-Enriched Gene Transcripts to Promote Breast Cancer Brain Metastasis. Cancer Cell38 (6), 857–871. 10.1016/j.ccell.2020.10.004
47
CheY.GengB.XuY.MiaoX.ChenL.MuX.et al (2018). Helicobacter pylori -induced Exosomal MET Educates Tumour-Associated Macrophages to Promote Gastric Cancer Progression. J. Cel Mol Med22 (11), 5708–5719. 10.1111/jcmm.13847
48
ChenD.ChenG.JiangW.FuM.LiuW.SuiJ.et al (2019). Association of the Collagen Signature in the Tumor Microenvironment with Lymph Node Metastasis in Early Gastric Cancer. JAMA Surg.154 (3), e185249. 10.1001/jamasurg.2018.5249
49
ChenG.HuangA. C.ZhangW.ZhangG.WuM.XuW.et al (2018). Exosomal PD-L1 Contributes to Immunosuppression and Is Associated with Anti-PD-1 Response. Nature560 (7718), 382–386. 10.1038/s41586-018-0392-8
50
ChenL.HanX. (2015). Anti-PD-1/PD-L1 Therapy of Human Cancer: Past, Present, and Future. J. Clin. Invest.125 (9), 3384–3391. 10.1172/JCI80011
51
ChenP. G.SchoeffS. S.WattsC. A.ReibelJ. F.LevineP. A.ShonkaD. C.Jr.et al (2014). Utility of Abdominal Imaging to Assess for Liver Metastasis in Patients with Head and Neck Cancer and Abnormal Liver Function Tests. Am. J. Otolaryngol.35 (2), 137–140. 10.1016/j.amjoto.2013.10.004
52
ChenX.ChenL.ZhuH.TaoJ. (2020). Risk Factors and Prognostic Predictors for Cervical Cancer Patients with Lung Metastasis. J. Cancer11 (20), 5880–5889. 10.7150/jca.46258
53
ChenY.GouX.KongD. K.WangX.WangJ.ChenZ.et al (2015). EMMPRIN Regulates Tumor Growth and Metastasis by Recruiting Bone Marrow-Derived Cells through Paracrine Signaling of SDF-1 and VEGF. Oncotarget6 (32), 32575–32585. 10.18632/oncotarget.5331
54
ChenZ.YangL.CuiY.ZhouY.YinX.GuoJ.et al (2016). Cytoskeleton-centric Protein Transportation by Exosomes Transforms Tumor-Favorable Macrophages. Oncotarget7 (41), 67387–67402. 10.18632/oncotarget.11794
55
ChengZ.LeiZ.YangP.SiA.XiangD.TangX.et al (2019). Exosome‐transmitted P120‐catenin Suppresses Hepatocellular Carcinoma Progression via STAT3 Pathways. Mol. Carcinog58 (8), 1389–1399. 10.1002/mc.23022
56
ChiC.FanZ.YangB.SunH.ZhengZ. (2021). The Clinical Characteristics and Prognostic Nomogram for Head and Neck Cancer Patients with Bone Metastasis. J. Oncol.2021, 1–12. 10.1155/2021/5859757
57
ChinA. R.WangS. E. (2016). Cancer Tills the Premetastatic Field: Mechanistic Basis and Clinical Implications. Clin. Cancer Res.22 (15), 3725–3733. 10.1158/1078-0432.CCR-16-0028
58
ChoiD.-S.KimD.-K.KimY.-K.GhoY. S. (2013). Proteomics, Transcriptomics and Lipidomics of Exosomes and Ectosomes. Proteomics13 (10-11), 1554–1571. 10.1002/pmic.201200329
59
CleverD.RoychoudhuriR.ConstantinidesM. G.AskenaseM. H.SukumarM.KlebanoffC. A.et al (2016). Oxygen Sensing by T Cells Establishes an Immunologically Tolerant Metastatic Niche. Cell166 (5), 1117–1131 e1114. 10.1016/j.cell.2016.07.032
60
Costa-SilvaB.AielloN. M.OceanA. J.SinghS.ZhangH.ThakurB. K.et al (2015). Pancreatic Cancer Exosomes Initiate Pre-metastatic Niche Formation in the Liver. Nat. Cel Biol17 (6), 816–826. 10.1038/ncb3169
61
CumsilleP.GodoyM.GerdtzenZ. P.ConcaC. (2019). Parameter Estimation and Mathematical Modeling for the Quantitative Description of Therapy Failure Due to Drug Resistance in Gastrointestinal Stromal Tumor Metastasis to the Liver. PLoS One14 (5), e0217332. 10.1371/journal.pone.0217332
62
CzernekL.DüchlerM. (2017). Functions of Cancer-Derived Extracellular Vesicles in Immunosuppression. Arch. Immunol. Ther. Exp.65 (4), 311–323. 10.1007/s00005-016-0453-3
63
da SilvaG. T.BergmannA.ThulerL. C. S. (2019). Incidence and Risk Factors for Bone Metastasis in Non-small Cell Lung Cancer. Asian Pac. J. Cancer Prev.20 (1), 45–51. 10.31557/APJCP.2019.20.1.45
64
DaiJ.Escara-WilkeJ.KellerJ. M.JungY.TaichmanR. S.PientaK. J.et al (2019). Primary Prostate Cancer Educates Bone Stroma through Exosomal Pyruvate Kinase M2 to Promote Bone Metastasis. J. Exp. Med.216 (12), 2883–2899. 10.1084/jem.20190158
65
DasS. K.PradhanA. K.BhoopathiP.TalukdarS.ShenX.-N.SarkarD.et al (2018). The MDA-9/Syntenin/IGF1R/STAT3 Axis Directs Prostate Cancer Invasion. Cancer Res.78 (11), 2852–2863. 10.1158/0008-5472.CAN-17-2992
66
DattaC. K.WeinsteinJ. D.BlandJ. E.BragerP. M.StewartM. A. (1998). A Case of Cervical Lymph Node Metastasis Resulting from Glioblastoma Multiforme. W V Med. J.94 (5), 276–278.
67
de la Cruz-MerinoL.Grande-PulidoE.Albero-TamaritA.Codes-Manuel de VillenaM. E. (2008). Cancer and Immune Response: Old and New Evidence for Future Challenges. Oncologist13 (12), 1246–1254. 10.1634/theoncologist.2008-0166
68
DeS.RazorenovaO.McCabeN. P.O'TooleT.QinJ.ByzovaT. V. (2005). VEGF-integrin Interplay Controls Tumor Growth and Vascularization. Proc. Natl. Acad. Sci.102 (21), 7589–7594. 10.1073/pnas.0502935102
69
DeepakP.AcharyaA. (2010). Anti-tumor Immunity and Mechanism of Immunosuppression Mediated by Tumor Cells: Role of Tumor-Derived Soluble Factors and Cytokines. Int. Rev. Immunol.29 (4), 421–458. 10.3109/08830185.2010.483027
70
Demory BecklerM.HigginbothamJ. N.FranklinJ. L.HamA.-J.HalveyP. J.ImasuenI. E.et al (2013). Proteomic Analysis of Exosomes from Mutant KRAS colon Cancer Cells Identifies Intercellular Transfer of Mutant KRAS. Mol. Cell Proteomics12 (2), 343–355. 10.1074/mcp.M112.022806
71
DengZ.RongY.TengY.ZhuangX.SamykuttyA.MuJ.et al (2017). Exosomes miR-126a Released from MDSC Induced by DOX Treatment Promotes Lung Metastasis. Oncogene36 (5), 639–651. 10.1038/onc.2016.229
72
DesgrosellierJ. S.ChereshD. A. (2010). Integrins in Cancer: Biological Implications and Therapeutic Opportunities. Nat. Rev. Cancer10 (1), 9–22. 10.1038/nrc2748
73
DeyM.FetckoK.GondimD.BonninJ. (2017). Cervical Cancer Metastasis to the Brain: A Case Report and Review of Literature. Surg. Neurol. Int.8, 181. 10.4103/sni.sni_111_17
74
Di ModicaM.RegondiV.SandriM.IorioM. V.ZanettiA.TagliabueE.et al (2017). Breast Cancer-Secreted miR-939 Downregulates VE-Cadherin and Destroys the Barrier Function of Endothelial Monolayers. Cancer Lett.384, 94–100. 10.1016/j.canlet.2016.09.013
75
DiepenbruckM.ChristoforiG. (2016). Epithelial-mesenchymal Transition (EMT) and Metastasis: Yes, No, Maybe?Curr. Opin. Cel Biol.43, 7–13. 10.1016/j.ceb.2016.06.002
76
DingJ.XuZ.ZhangY.TanC.HuW.WangM.et al (2018). Exosome-mediated miR-222 Transferring: An Insight into NF-Κb-Mediated Breast Cancer Metastasis. Exp. Cel Res.369 (1), 129–138. 10.1016/j.yexcr.2018.05.014
77
DolmanC. L. (1974). Lymph Node Metastasis as First Manifestation of Glioblastoma. J. Neurosurg.41 (5), 607–609. 10.3171/jns.1974.41.5.0607
78
DoshiT. V.DoshiJ. V.MakaryusJ. N.MakaryusA. N. (2013). A Rare Case of Successfully Treated Cardiac Metastasis from Transitional Cell Bladder Cancer. Am. J. Ther.20 (3), 307–310. 10.1097/MJT.0b013e3181f6c131
79
DuQ.YeX.LuS.-R.LiH.LiuH.-Y.ZhaiQ.et al (2021). Exosomal miR-30a and miR-222 Derived from colon Cancer Mesenchymal Stem Cells Promote the Tumorigenicity of colon Cancer through Targeting MIA3. J. Gastrointest. Oncol.12 (1), 52–68. 10.21037/jgo-20-513
80
EbleJ. A.NilandS. (2019). The Extracellular Matrix in Tumor Progression and Metastasis. Clin. Exp. Metastasis36 (3), 171–198. 10.1007/s10585-019-09966-1
81
EkströmE. J.BergenfelzC.von BülowV.SeriflerF.CarlemalmE.JönssonG.et al (2014). WNT5A Induces Release of Exosomes Containing Pro-angiogenic and Immunosuppressive Factors from Malignant Melanoma Cells. Mol. Cancer13, 88. 10.1186/1476-4598-13-88
82
El-HalabiM. M.ChaabanS. A.MeouchyJ.PageS.SalyersW. J.Jr. (2014). Colon Cancer Metastasis to Mediastinal Lymph Nodes without Liver or Lung Involvement: A Case Report. Oncol. Lett.8 (5), 2221–2224. 10.3892/ol.2014.2426
83
ElsnerL.MuppalaV.GehrmannM.LozanoJ.MalzahnD.BickeböllerH.et al (2007). The Heat Shock Protein HSP70 Promotes Mouse NK Cell Activity against Tumors that Express Inducible NKG2D Ligands. J. Immunol.179 (8), 5523–5533. 10.4049/jimmunol.179.8.5523
84
Estelles PieraF.Peris GodoyM.Saro PérezE.Calabuig AlborchJ. R. (1993). Multiple Myeloma and Adenocarcinoma Liver Metastasis. Med. Interna10 (7), 363.
85
EtohT.BabaH.AdachiE.KohnoeS.SeoY.SaitoT.et al (1997). A Case of Liver Metastasis of Malignant Peritoneal Mesothelioma Successfully Treated by Surgery. Oncol. Rep.4 (4), 803–805. 10.3892/or.4.4.803
86
FanZ.HuangZ.HuC.TongY.ZhaoC. (2020). Risk Factors and Nomogram for Newly Diagnosis of Bone Metastasis in Bladder Cancer. Medicine (Baltimore)99 (42), e22675. 10.1097/MD.0000000000022675
87
FangJ. H.ZhangZ. J.ShangL. R.LuoY. W.LinY. F.YuanY.et al (2018). Hepatoma Cell‐secreted Exosomal microRNA‐103 Increases Vascular Permeability and Promotes Metastasis by Targeting junction Proteins. Hepatology68 (4), 1459–1475. 10.1002/hep.29920
88
FangT.LvH.LvG.LiT.WangC.HanQ.et al (2018). Tumor-derived Exosomal miR-1247-3p Induces Cancer-Associated Fibroblast Activation to foster Lung Metastasis of Liver Cancer. Nat. Commun.9 (1), 191. 10.1038/s41467-017-02583-0
89
FangW.-Y.KuoY.-Z.ChangJ.-Y.HsiaoJ.-R.KaoH.-Y.TsaiS.-T.et al (2020). The Tumor Suppressor TGFBR3 Blocks Lymph Node Metastasis in Head and Neck Cancer. Cancers12 (6), 1375. 10.3390/cancers12061375
90
FariesM. B.HanD.ReintgenM.KerivanL.ReintgenD.CaracòC. (2018). Lymph Node Metastasis in Melanoma: a Debate on the Significance of Nodal Metastases, Conditional Survival Analysis and Clinical Trials. Clin. Exp. Metastasis35 (5-6), 431–442. 10.1007/s10585-018-9898-6
91
FelchtM.LuckR.ScheringA.SeidelP.SrivastavaK.HuJ.et al (2012). Angiopoietin-2 Differentially Regulates Angiogenesis through TIE2 and Integrin Signaling. J. Clin. Invest.122 (6), 1991–2005. 10.1172/JCI58832
92
FidlerI. J.KripkeM. L. (2015). The challenge of Targeting Metastasis. Cancer Metastasis Rev.34 (4), 635–641. 10.1007/s10555-015-9586-9
93
FongM. Y.ZhouW.LiuL.AlontagaA. Y.ChandraM.AshbyJ.et al (2015). Breast-cancer-secreted miR-122 Reprograms Glucose Metabolism in Premetastatic Niche to Promote Metastasis. Nat. Cel Biol17 (2), 183–194. 10.1038/ncb3094
94
FuQ.ZhangQ.LouY.YangJ.NieG.ChenQ.et al (2018). Primary Tumor-Derived Exosomes Facilitate Metastasis by Regulating Adhesion of Circulating Tumor Cells via SMAD3 in Liver Cancer. Oncogene37 (47), 6105–6118. 10.1038/s41388-018-0391-0
95
FujimotoT.NakagawaS.MorofujiY.WatanabeD.UjifukuK.HorieN.et al (2020). Pericytes Suppress Brain Metastasis from Lung Cancer In Vitro. Cell Mol Neurobiol40 (1), 113–121. 10.1007/s10571-019-00725-0
96
FujitaI.ToyokawaT.MakinoT.MatsuedaK.OmoteS.HoriiJ. (2020). Small Early Gastric Cancer with Synchronous Bone Metastasis: A Case Report. Mol. Clin. Onc12 (3), 202–207. 10.3892/mco.2020.1985
97
GarcíaS. A.WeitzJ.SchölchS. (2018). Circulating Tumor Cells. Methods Mol. Biol.1692, 213–219. 10.1007/978-1-4939-7401-6_18
98
Garcia-DiazA.ShinD. S.MorenoB. H.SacoJ.Escuin-OrdinasH.RodriguezG. A.et al (2019). Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression. Cel Rep.29 (11), 3766. 10.1016/j.celrep.2019.11.113
99
GarnierD.MagnusN.LeeT. H.BentleyV.MeehanB.MilsomC.et al (2012). Cancer Cells Induced to Express Mesenchymal Phenotype Release Exosome-like Extracellular Vesicles Carrying Tissue Factor. J. Biol. Chem.287 (52), 43565–43572. 10.1074/jbc.M112.401760
100
GinestraA.MoneaS.SeghezziG.DoloV.NagaseH.MignattiP.et al (1997). Urokinase Plasminogen Activator and Gelatinases Are Associated with Membrane Vesicles Shed by Human HT1080 Fibrosarcoma Cells. J. Biol. Chem.272 (27), 17216–17222. 10.1074/jbc.272.27.17216
101
GoetzlE. J.GoetzlL.KarlinerJ. S.TangN.PulliamL. (2016). Human Plasma Platelet‐derived Exosomes: Effects of Aspirin. FASEB j.30 (5), 2058–2063. 10.1096/fj.201500150R
102
GreeningD. W.GopalS. K.XuR.SimpsonR. J.ChenW. (2015). Exosomes and Their Roles in Immune Regulation and Cancer. Semin. Cel Dev. Biol.40, 72–81. 10.1016/j.semcdb.2015.02.009
103
GrivennikovS. I.GretenF. R.KarinM. (2010). Immunity, Inflammation, and Cancer. Cell140 (6), 883–899. 10.1016/j.cell.2010.01.025
104
GrossniklausH. E. (2019). Understanding Uveal Melanoma Metastasis to the Liver: The Zimmerman Effect and the Zimmerman Hypothesis. Ophthalmology126 (4), 483–487. 10.1016/j.ophtha.2018.09.031
105
GuanZ.LanH.ChenX.JiangX.WangX.JinK. (2017). Individualized Drug Screening Based on Next Generation Sequencing and Patient Derived Xenograft Model for Pancreatic Cancer with Bone Metastasis. Mol. Med. Rep.16 (4), 4784–4790. 10.3892/mmr.2017.7213
106
GuoY.JiX.LiuJ.FanD.ZhouQ.ChenC.et al (2019). Effects of Exosomes on Pre-metastatic Niche Formation in Tumors. Mol. Cancer18 (1), 39. 10.1186/s12943-019-0995-1
107
HanQ.LvL.WeiJ.LeiX.LinH.LiG.et al (2019). Vps4A Mediates the Localization and Exosome Release of β-catenin to Inhibit Epithelial-Mesenchymal Transition in Hepatocellular Carcinoma. Cancer Lett.457, 47–59. 10.1016/j.canlet.2019.04.035
108
HashimotoK.OchiH.SunamuraS.KosakaN.MabuchiY.FukudaT.et al (2018). Cancer-secreted Hsa-miR-940 Induces an Osteoblastic Phenotype in the Bone Metastatic Microenvironment via Targeting ARHGAP1 and FAM134A. Proc. Natl. Acad. Sci. USA115 (9), 2204–2209. 10.1073/pnas.1717363115
109
HeJ.ShiJ.ZhangK.XueJ.LiJ.YangJ.et al (2017). Sox2 Inhibits Wnt-β-Catenin Signaling and Metastatic Potency of Cisplatin-Resistant Lung Adenocarcinoma Cells. Mol. Med. Rep.15 (4), 1693–1701. 10.3892/mmr.2017.6170
110
Hernández-EsquivelM. A.Pérez-TorresA.Romero-RomeroL.Reyes-MatuteA.LoaizaB.Mellado-SánchezG.et al (2018). The Dialyzable Leukocyte Extract TransferonTM Inhibits Tumor Growth and Brain Metastasis in a Murine Model of Prostate Cancer. Biomed. Pharmacother.101, 938–944. 10.1016/j.biopha.2018.03.012
111
HirookaA.TamiyaA.KanazuM.NonakaJ.YonezawaT.AsamiK.et al (2016). Brain Metastasis of Pleural Mesothelioma after a Subarachnoid Hemorrhage. Intern. Med.55 (7), 779–781. 10.2169/internalmedicine.55.3765
112
HoT. T. B.NastiA.SekiA.KomuraT.InuiH.KozakaT.et al (2020). Combination of Gemcitabine and Anti-PD-1 Antibody Enhances the Anticancer Effect of M1 Macrophages and the Th1 Response in a Murine Model of Pancreatic Cancer Liver Metastasis. J. Immunother. Cancer8 (2), e001367. 10.1136/jitc-2020-001367
113
HoffmanH. A.LiC. H.EversonR. G.StrunckJ. L.YongW. H.LuD. C. (2017). Primary Lung Metastasis of Glioblastoma Multiforme with Epidural Spinal Metastasis: Case Report. J. Clin. Neurosci.41, 97–99. 10.1016/j.jocn.2017.03.033
114
HongC.-S.SharmaP.YerneniS. S.SimmsP.JacksonE. K.WhitesideT. L.et al (2017). Circulating Exosomes Carrying an Immunosuppressive Cargo Interfere with Cellular Immunotherapy in Acute Myeloid Leukemia. Sci. Rep.7 (1), 14684. 10.1038/s41598-017-14661-w
115
HongL.QiuH.MeiZ.ZhangH.LiuS.CaoH. (2018). Ovarian Cancer Initially Presenting with Supra-clavicular L-ymph N-ode M-etastasis: A C-ase R-eport. Oncol. Lett.16 (1), 505–510. 10.3892/ol.2018.8664
116
HoodJ. L.SanR. S.WicklineS. A. (2011). Exosomes Released by Melanoma Cells Prepare sentinel Lymph Nodes for Tumor Metastasis. Cancer Res.71 (11), 3792–3801. 10.1158/0008-5472.CAN-10-4455
117
HoshinoA.Costa-SilvaB.ShenT.-L.RodriguesG.HashimotoA.Tesic MarkM.et al (2015). Tumour Exosome Integrins Determine Organotropic Metastasis. Nature527 (7578), 329–335. 10.1038/nature15756
118
HosonagaM.SayaH.ArimaY. (2020). Molecular and Cellular Mechanisms Underlying Brain Metastasis of Breast Cancer. Cancer Metastasis Rev.39 (3), 711–720. 10.1007/s10555-020-09881-y
119
HsiehY.-S.ChuS.-C.HuangS.-C.KaoS.-H.LinM.-S.ChenP.-N. (2021). Gossypol Reduces Metastasis and Epithelial-Mesenchymal Transition by Targeting Protease in Human Cervical Cancer. Am. J. Chin. Med.49 (1), 181–198. 10.1142/S0192415X21500105
120
HsuY.-L.HungJ.-Y.ChangW.-A.JianS.-F.LinY.-S.PanY.-C.et al (2018). Hypoxic Lung-Cancer-Derived Extracellular Vesicle MicroRNA-103a Increases the Oncogenic Effects of Macrophages by Targeting PTEN. Mol. Ther.26 (2), 568–581. 10.1016/j.ymthe.2017.11.016
121
HsuY.-L.HungJ.-Y.ChangW.-A.LinY.-S.PanY.-C.TsaiP.-H.et al (2017). Hypoxic Lung Cancer-Secreted Exosomal miR-23a Increased Angiogenesis and Vascular Permeability by Targeting Prolyl Hydroxylase and Tight junction Protein ZO-1. Oncogene36 (34), 4929–4942. 10.1038/onc.2017.105
122
HuC.YangJ.HuangZ.LiuC.LinY.TongY.et al (2020). Diagnostic and Prognostic Nomograms for Bone Metastasis in Hepatocellular Carcinoma. BMC Cancer20 (1), 494. 10.1186/s12885-020-06995-y
123
HuH.-Y.YuC.-H.ZhangH.-H.ZhangS.-Z.YuW.-Y.YangY.et al (2019). Exosomal miR-1229 Derived from Colorectal Cancer Cells Promotes Angiogenesis by Targeting HIPK2. Int. J. Biol. Macromolecules132, 470–477. 10.1016/j.ijbiomac.2019.03.221
124
HuJ. L.WangW.LanX. L.ZengZ. C.LiangY. S.YanY. R.et al (2019). CAFs Secreted Exosomes Promote Metastasis and Chemotherapy Resistance by Enhancing Cell Stemness and Epithelial-Mesenchymal Transition in Colorectal Cancer. Mol. Cancer18 (1), 91. 10.1186/s12943-019-1019-x
125
HuY.LiD.WuA.QiuX.DiW.HuangL.et al (2017). TWEAK-stimulated Macrophages Inhibit Metastasis of Epithelial Ovarian Cancer via Exosomal Shuttling of microRNA. Cancer Lett.393, 60–67. 10.1016/j.canlet.2017.02.009
126
HuangC.-S.HoJ.-Y.ChiangJ.-H.YuC.-P.YuD.-S. (2020a). Exosome-Derived LINC00960 and LINC02470 Promote the Epithelial-Mesenchymal Transition and Aggressiveness of Bladder Cancer Cells. Cells9 (6), 1419. 10.3390/cells9061419
127
HuangR.RofstadE. K. (2018). Integrins as Therapeutic Targets in the Organ-specific Metastasis of Human Malignant Melanoma. J. Exp. Clin. Cancer Res.37 (1), 92. 10.1186/s13046-018-0763-x
128
HuangR.WuJ.ZhengZ.WangG.SongD.YanP.et al (2019). The Construction and Analysis of ceRNA Network and Patterns of Immune Infiltration in Mesothelioma with Bone Metastasis. Front. Bioeng. Biotechnol.7, 257. 10.3389/fbioe.2019.00257
129
HuangX.-Y.HuangZ.-L.HuangJ.XuB.HuangX.-Y.XuY.-H.et al (2020b). Exosomal circRNA-100338 Promotes Hepatocellular Carcinoma Metastasis via Enhancing Invasiveness and Angiogenesis. J. Exp. Clin. Cancer Res.39 (1), 20. 10.1186/s13046-020-1529-9
130
HwangJ. H.YooH. J.LimM. C.SeoS.-S.KangS.KimJ.-Y.et al (2013). Brain Metastasis in Patients with Uterine Cervical Cancer. J. Obstet. Gynaecol. Res.39 (1), 287–291. 10.1111/j.1447-0756.2012.01927.x
131
HyunY.-M.SeoS.-U.ChoiW. S.KwonH.-J.KimD.-Y.JeongS.et al (2020). Endogenous DEL-1 Restrains Melanoma Lung Metastasis by Limiting Myeloid Cell-Associated Lung Inflammation. Sci. Adv.6 (45). 10.1126/sciadv.abc4882
132
IkegamiT.YoshizumiT.KawasakiJ.NagatsuA.UchiyamaH.HaradaN.et al (2017). Surgical Resection for Lymph Node Metastasis after Liver Transplantation for Hepatocellular Carcinoma. Ar37 (2), 891–896. 10.21873/anticanres.11395
133
ImuraY.TateiwaD.SugimotoN.InoueA.WakamatsuT.OutaniH.et al (2020). Prognostic Factors and Skeletal-related E-vents in P-atients with B-one M-etastasis from G-astric C-ancer. Mol. Clin. Oncol.13 (4), 31. 10.3892/mco.2020.2101
134
JamjoomA. B.JamjoomZ. A. B.RahmanN.-U.Al-RikabiA. C. (1997). Cervical Lymph Node Metastasis from a Glioblastoma Multiforme in a Child: Report of a Case and a Review of the Literature. Ann. Saudi Med.17 (3), 340–343. 10.5144/0256-4947.1997.340
135
JiL.FanL.ZhuX.GaoY.WangZ. (2020). A Prognostic Model for Breast Cancer with Liver Metastasis. Front. Oncol.10, 1342. 10.3389/fonc.2020.01342
136
JiangK.DongC.YinZ.LiR.MaoJ.WangC.et al (2020). Exosome-derived ENO1 Regulates Integrin α6β4 Expression and Promotes Hepatocellular Carcinoma Growth and Metastasis. Cel Death Dis11 (11), 972. 10.1038/s41419-020-03179-1
137
JieG. N.SingW. C.ChingC. Y.Tiffanyfnm. (2011). Is Lymph Node Metastasis a Common Feature of Gastrointestinal Stromal Tumor?Clin. Nucl. Med.36 (8), 678–682. 10.1097/RLU.0b013e318219ad31
138
KalluriR. (2016). The Biology and Function of Exosomes in Cancer. J. Clin. Invest.126 (4), 1208–1215. 10.1172/JCI81135
139
KanayamaT.MabuchiS.ShimuraK.HisamatsuT.IsohashiF.HamasakiT.et al (2015). Prognostic Factors for Survival in Cervical Cancer Patients with Bone Metastasis. Eur. J. Gynaecol. Oncol.36 (3), 290–293.
140
KandaM.FujiiT.NagaiS.KoderaY.KanzakiA.SahinT. T.et al (2011). Pattern of Lymph Node Metastasis Spread in Pancreatic Cancer. Pancreas40 (6), 951–955. 10.1097/MPA.0b013e3182148342
141
KapoorH.SanampudiS.OwenJ.RaissiD. (2020). Lung Metastasis Postradioembolization of Hepatocellular Carcinoma with Tumor in Vein. ACG Case Rep. J.7 (2), e00322. 10.14309/crj.0000000000000322
142
KatonaF.MurnyákB.Marko-VargaG.HortobágyiT. (2017). A Melanoma És Az Agyi Áttétképződés Molekuláris Háttere. Orvosi Hetilap158 (28), 1083–1091. 10.1556/650.2017.30793
143
KawaiA.NagasakaY.MurakiM.FukuokaM.SatouT.KimuraM.et al (1997). Brain Metastasis in Malignant Pleural Mesothelioma. Intern. Med.36 (8), 591–594. 10.2169/internalmedicine.36.591
144
KhanS.AspeJ. R.AsumenM. G.AlmaguelF.OdumosuO.Acevedo-MartinezS.et al (2009). Extracellular, Cell-Permeable Survivin Inhibits Apoptosis while Promoting Proliferative and Metastatic Potential. Br. J. Cancer100 (7), 1073–1086. 10.1038/sj.bjc.6604978
145
KhanS.JutzyJ. M. S.AspeJ. R.McGregorD. W.NeidighJ. W.WallN. R. (2011). Survivin Is Released from Cancer Cells via Exosomes. Apoptosis16 (1), 1–12. 10.1007/s10495-010-0534-4
146
KimE.-K.SongM.-J.JungY.LeeW.-S.JangH. H. (2019a). Proteomic Analysis of Primary Colon Cancer and Synchronous Solitary Liver Metastasis. Cancer Genomics Proteomics16 (6), 583–592. 10.21873/cgp.20161
147
KimH.LeeK. K.HeoM. H.KimJ. Y. (2019b). The Prognostic Factors Influencing Overall Survival in Uterine Cervical Cancer with Brain Metastasis. Korean J. Intern. Med.34 (6), 1324–1332. 10.3904/kjim.2018.051
148
KimJ.PiaoH.-L.KimB.-J.YaoF.HanZ.WangY.et al (2018). Long Noncoding RNA MALAT1 Suppresses Breast Cancer Metastasis. Nat. Genet.50 (12), 1705–1715. 10.1038/s41588-018-0252-3
149
KimJ. W.WieckowskiE.TaylorD. D.ReichertT. E.WatkinsS.WhitesideT. L. (2005). Fas Ligand-Positive Membranous Vesicles Isolated from Sera of Patients with Oral Cancer Induce Apoptosis of Activated T Lymphocytes. Clin. Cancer Res.11 (3), 1010–1020. 10.1158/1078-0432.ccr-05-1346
150
KimR.SongJ.KimS. B. (2020). Concurrent Hepatocellular Carcinoma Metastasis to Stomach, colon, and Brain: A Case Report. Wjcc8 (16), 3534–3541. 10.12998/wjcc.v8.i16.3534
151
KimS.BaeW. J.AhnJ. M.HeoJ.-H.KimK.-M.ChoiK. W.et al (2021). MicroRNA Signatures Associated with Lymph Node Metastasis in Intramucosal Gastric Cancer. Mod. Pathol.34 (3), 672–683. 10.1038/s41379-020-00681-x
152
KimW.Seok KangY.Soo KimJ.ShinN.-Y.HanksS. K.SongW. K. (2008). The Integrin-Coupled Signaling Adaptor p130Cas Suppresses Smad3 Function in Transforming Growth Factor-β Signaling. MBoC19 (5), 2135–2146. 10.1091/mbc.E07-10-0991
153
KircherD.SilvisM.ChoJ.HolmenS. (2016). Melanoma Brain Metastasis: Mechanisms, Models, and Medicine. Ijms17 (9), 1468. 10.3390/ijms17091468
154
KlemkeM.WeschenfelderT.KonstandinM. H.SamstagY. (2007). High Affinity Interaction of Integrin α4β1 (VLA-4) and Vascular Cell Adhesion Molecule 1 (VCAM-1) Enhances Migration of Human Melanoma Cells across Activated Endothelial Cell Layers. J. Cel. Physiol.212 (2), 368–374. 10.1002/jcp.21029
155
KleppeM.WangT.Van GorpT.SlangenB. F. M.KruseA. J.KruitwagenR. F. P. M. (2011). Lymph Node Metastasis in Stages I and II Ovarian Cancer: a Review. Gynecol. Oncol.123 (3), 610–614. 10.1016/j.ygyno.2011.09.013
156
KlingenbergS.JochumsenM. R.UlhøiB. P.FredsøeJ.SørensenK. D.BorreM.et al (2021). 68Ga-PSMA PET/CT for Primary Lymph Node and Distant Metastasis NM Staging of High-Risk Prostate Cancer. J. Nucl. Med.62 (2), 214–220. 10.2967/jnumed.120.245605
157
KoflerB.KerschbaumerJ.SchartingerV. H.PoschA.GizewskiE. R.WidmannG. (2017). Hirnmetastase versus Strahlennekrose nach Kopf-Hals-Karzinom. Radiologe57 (5), 392–396. 10.1007/s00117-017-0219-x
158
KogureT.LinW.-L.YanI. K.BraconiC.PatelT. (2011). Intercellular Nanovesicle-Mediated microRNA Transfer: a Mechanism of Environmental Modulation of Hepatocellular Cancer Cell Growth. Hepatology54 (4), 1237–1248. 10.1002/hep.24504
159
KongJ.TianH.ZhangF.ZhangZ.LiJ.LiuX.et al (2019). Extracellular Vesicles of Carcinoma-Associated Fibroblasts Creates a Pre-metastatic Niche in the Lung through Activating Fibroblasts. Mol. Cancer18 (1), 175. 10.1186/s12943-019-1101-4
160
KongM.JinJ.CaiX.ShenJ.MaD.YeM.et al (2017). Characteristics of Lymph Node Metastasis in Resected Adenosquamous Lung Cancer. Medicine (Baltimore)96 (48), e8870. 10.1097/MD.0000000000008870
161
KongX.ZhangJ.LiJ.ShaoJ.FangL. (2018). MiR-130a-3p Inhibits Migration and Invasion by Regulating RAB5B in Human Breast Cancer Stem Cell-like Cells. Biochem. Biophysical Res. Commun.501 (2), 486–493. 10.1016/j.bbrc.2018.05.018
162
KoppH.-G.PlackeT.SalihH. R. (2009). Platelet-Derived Transforming Growth Factor-β Down-Regulates NKG2D Thereby Inhibiting Natural Killer Cell Antitumor Reactivity. Cancer Res.69 (19), 7775–7783. 10.1158/0008-5472.CAN-09-2123
163
KosakaN.IguchiH.HagiwaraK.YoshiokaY.TakeshitaF.OchiyaT. (2013). Neutral Sphingomyelinase 2 (nSMase2)-dependent Exosomal Transfer of Angiogenic microRNAs Regulate Cancer Cell Metastasis. J. Biol. Chem.288 (15), 10849–10859. 10.1074/jbc.M112.446831
164
KuboN.TakeuchiN. (2017). Gastrointestinal Stromal Tumor of the Stomach with Axillary Lymph Node Metastasis: A Case Report. Wjg23 (9), 1720–1724. 10.3748/wjg.v23.i9.1720
165
KucharzewskaP.ChristiansonH. C.WelchJ. E.SvenssonK. J.FredlundE.RingnerM.et al (2013). Exosomes Reflect the Hypoxic Status of Glioma Cells and Mediate Hypoxia-dependent Activation of Vascular Cells during Tumor Development. Proc. Natl. Acad. Sci.110 (18), 7312–7317. 10.1073/pnas.1220998110
166
KumarL.BhargavaV. L.RaoR. C. K.RathG. K.KatariaS. P. (1992). Bone Metastasis in Ovarian Cancer. Asia Oceania J. Obstet. Gynaecol.18 (4), 309–313. 10.1111/j.1447-0756.1992.tb00324.x
167
KuoS.-W.KeF.-C.ChangG.-D.LeeM.-T.HwangJ.-J. (2011). Potential Role of Follicle-Stimulating Hormone (FSH) and Transforming Growth Factor (TGFβ1) in the Regulation of Ovarian Angiogenesis. J. Cel. Physiol.226 (6), 1608–1619. 10.1002/jcp.22491
168
KuznetsovH. S.MarshT.MarkensB. A.CastañoZ.Greene-ColozziA.HayS. A.et al (2012). Identification of Luminal Breast Cancers that Establish a Tumor-Supportive Macroenvironment Defined by Proangiogenic Platelets and Bone Marrow-Derived Cells. Cancer Discov.2 (12), 1150–1165. 10.1158/2159-8290.CD-12-0216
169
LalP.TiwariA.KumarN.BajpaiR. (2007). Bone Metastasis from Ovarian Cancer. J. Can. Res. Ther.3 (1), 34–36. 10.4103/0973-1482.31969
170
LambertA. W.PattabiramanD. R.WeinbergR. A. (2017). Emerging Biological Principles of Metastasis. Cell168 (4), 670–691. 10.1016/j.cell.2016.11.037
171
LanJ.SunL.XuF.LiuL.HuF.SongD.et al (2019). M2 Macrophage-Derived Exosomes Promote Cell Migration and Invasion in Colon Cancer. Cancer Res.79 (1), 146–158. 10.1158/0008-5472.CAN-18-0014
172
LangH.-L.HuG.-W.ZhangB.KuangW.ChenY.WuL.et al (2017b). Glioma Cells Enhance Angiogenesis and Inhibit Endothelial Cell Apoptosis through the Release of Exosomes that Contain Long Non-coding RNA CCAT2. Oncol. Rep.38 (2), 785–798. 10.3892/or.2017.5742
173
LangH. L.HuG. W.ChenY.LiuY.TuW.LuY. M.et al (2017a). Glioma Cells Promote Angiogenesis through the Release of Exosomes Containing Long Non-coding RNA POU3F3. Eur. Rev. Med. Pharmacol. Sci.21 (5), 959–972.
174
LauriniR. N. (1974). Diffuse Pleural Mesothelioma with Distant Bone Metastasis. Acta Pathol. Microbiol. Scand. A.82A (2), 296–298. 10.1111/j.1699-0463.1974.tb03854.x
175
Lázaro‐IbáñezE.Sanz‐GarciaA.VisakorpiT.Escobedo‐LuceaC.SiljanderP.Ayuso‐SacidoÁ.et al (2014). Different gDNA Content in the Subpopulations of Prostate Cancer Extracellular Vesicles: Apoptotic Bodies, Microvesicles, and Exosomes. Prostate74 (14), 1379–1390. 10.1002/pros.22853
176
LeeJ.-K.ParkS.-R.JungB.-K.JeonY.-K.LeeY.-S.KimM.-K.et al (2013b). Exosomes Derived from Mesenchymal Stem Cells Suppress Angiogenesis by Down-Regulating VEGF Expression in Breast Cancer Cells. PLoS One8 (12), e84256. 10.1371/journal.pone.0084256
177
LeeJ.KimK. E.ChoiD.-K.JangJ. Y.JungJ.-J.KiyonariH.et al (2013a). Angiopoietin-1 Guides Directional Angiogenesis through Integrin α V β 5 Signaling for Recovery of Ischemic Retinopathy. Sci. Transl. Med.5 (203), 203ra127. 10.1126/scitranslmed.3006666
178
LeightJ. L.WozniakM. A.ChenS.LynchM. L.ChenC. S. (2012). Matrix Rigidity Regulates a Switch between TGF-Β1-Induced Apoptosis and Epithelial-Mesenchymal Transition. MBoC23 (5), 781–791. 10.1091/mbc.E11-06-0537
179
LeitingerB. (2011). Transmembrane Collagen Receptors. Annu. Rev. Cel Dev. Biol.27, 265–290. 10.1146/annurev-cellbio-092910-154013
180
LemkeJ.ScheeleJ.KapapaT.WirtzC.Henne-BrunsD.KornmannM. (2013). Brain Metastasis in Pancreatic Cancer. Ijms14 (2), 4163–4173. 10.3390/ijms14024163
181
LeventalK. R.YuH.KassL.LakinsJ. N.EgebladM.ErlerJ. T.et al (2009). Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin Signaling. Cell139 (5), 891–906. 10.1016/j.cell.2009.10.027
182
LiB.MaoR.LiuC.ZhangW.TangY.GuoZ. (2018). LncRNA FAL1 Promotes Cell Proliferation and Migration by Acting as a CeRNA of miR-1236 in Hepatocellular Carcinoma Cells. Life Sci.197, 122–129. 10.1016/j.lfs.2018.02.006
183
LiF.DaiY.XuH.HuangK.ZhouY.LuoD.et al (2019). XPNPEP2 Is Associated with Lymph Node Metastasis in Prostate Cancer Patients. Sci. Rep.9 (1), 10078. 10.1038/s41598-019-45245-5
184
LiJ.LiZ.JiangP.PengM.ZhangX.ChenK.et al (2018). Circular RNA IARS (Circ-IARS) Secreted by Pancreatic Cancer Cells and Located within Exosomes Regulates Endothelial Monolayer Permeability to Promote Tumor Metastasis. J. Exp. Clin. Cancer Res.37 (1), 177. 10.1186/s13046-018-0822-3
185
LiK.ChenY.LiA.TanC.LiuX. (2019). Exosomes Play Roles in Sequential Processes of Tumor Metastasis. Int. J. Cancer144 (7), 1486–1495. 10.1002/ijc.31774
186
LiR.WangY.ZhangX.FengM.MaJ.LiJ.et al (2019). Exosome-mediated Secretion of LOXL4 Promotes Hepatocellular Carcinoma Cell Invasion and Metastasis. Mol. Cancer18 (1), 18. 10.1186/s12943-019-0948-8
187
LiY.LiQ.LiD.GuJ.QianD.QinX.et al (2021). Exosome Carrying PSGR Promotes Stemness and Epithelial-Mesenchymal Transition of Low Aggressive Prostate Cancer Cells. Life Sci.264, 118638. 10.1016/j.lfs.2020.118638
188
LiY.LiangY.SangY.SongX.ZhangH.LiuY.et al (2018). MiR-770 Suppresses the Chemo-Resistance and Metastasis of Triple Negative Breast Cancer via Direct Targeting of STMN1. Cel Death Dis9 (1), 14. 10.1038/s41419-017-0030-7
189
LiY.XiY.ZhuG.JiaJ.HuangH.LiuY.et al (2019). Downregulated IGFBP7 Facilitates Liver Metastasis by Modulating Epithelial-mesenchymal T-ransition in colon C-ancer. Oncol. Rep.42 (5), 1935–1945. 10.3892/or.2019.7303
190
LiZ.JiangP.LiJ.PengM.ZhaoX.ZhangX.et al (2018). Tumor-derived Exosomal Lnc-Sox2ot Promotes EMT and Stemness by Acting as a ceRNA in Pancreatic Ductal Adenocarcinoma. Oncogene37 (28), 3822–3838. 10.1038/s41388-018-0237-9
191
LinW.-H.ChangY.-W.HongM.-X.HsuT.-C.LeeK.-C.LinC.et al (2021). STAT3 Phosphorylation at Ser727 and Tyr705 Differentially Regulates the EMT-MET Switch and Cancer Metastasis. Oncogene40 (4), 791–805. 10.1038/s41388-020-01566-8
192
LinY.HuangS.-T.JiangY.-M.PanX.-B. (2017). Hemorrhage of Brain Metastasis Is a Poor Prognostic Factor in Hepatocellular Carcinoma Patients. Oncotarget8 (54), 93245–93250. 10.18632/oncotarget.21449
193
LiuD.KangH.GaoM.JinL.ZhangF.ChenD.et al (2020). Exosome‐transmitted circ_MMP2 Promotes Hepatocellular Carcinoma Metastasis by Upregulating MMP2. Mol. Oncol.14 (6), 1365–1380. 10.1002/1878-0261.12637
194
LiuH.YeX.LiD.YaoQ.LiY. (2021). Incidence, Clinical Risk and Prognostic Factors for Liver Metastasis in Patients with Cervical Cancer: a Population-Based Retrospective Study. BMC Cancer21 (1), 421. 10.1186/s12885-021-08127-6
195
LiuJ.AgarwalS. (2010). Mechanical Signals Activate Vascular Endothelial Growth Factor Receptor-2 to Upregulate Endothelial Cell Proliferation during Inflammation. J.I.185 (2), 1215–1221. 10.4049/jimmunol.0903660
196
LiuT.ZhangX.DuL.WangY.LiuX.TianH.et al (2019). Exosome-transmitted miR-128-3p Increase Chemosensitivity of Oxaliplatin-Resistant Colorectal Cancer. Mol. Cancer18 (1), 43. 10.1186/s12943-019-0981-7
197
LiuY.CaoX. (2016). Characteristics and Significance of the Pre-metastatic Niche. Cancer Cell30 (5), 668–681. 10.1016/j.ccell.2016.09.011
198
LiuY.GuY.HanY.ZhangQ.JiangZ.ZhangX.et al (2016a). Tumor Exosomal RNAs Promote Lung Pre-metastatic Niche Formation by Activating Alveolar Epithelial TLR3 to Recruit Neutrophils. Cancer Cell30 (2), 243–256. 10.1016/j.ccell.2016.06.021
199
LiuY.LuoF.WangB.LiH.XuY.LiuX.et al (2016b). STAT3-regulated Exosomal miR-21 Promotes Angiogenesis and Is Involved in Neoplastic Processes of Transformed Human Bronchial Epithelial Cells. Cancer Lett.370 (1), 125–135. 10.1016/j.canlet.2015.10.011
200
LiuY.RenW.BaiY.WanL.SunX.LiuY.et al (2018a). Oxyresveratrol Prevents Murine H22 Hepatocellular Carcinoma Growth and Lymph Node Metastasis via Inhibiting Tumor Angiogenesis and Lymphangiogenesis. J. Nat. Med.72 (2), 481–492. 10.1007/s11418-018-1173-2
201
LiuY.WuT.LuD.ZhenJ.ZhangL. (2018b). CD44 Overexpression Related to Lymph Node Metastasis and Poor Prognosis of Pancreatic Cancer. Int. J. Biol. Markers33 (3), 308–313. 10.1177/1724600817746951
202
LiuZ.-L.WangC.ChenH.-J.LiX.DaiL.-J.DingZ.-Y. (2017). Bone Metastasis from Lung Cancer Identified by Genetic Profiling. Oncol. Lett.13 (2), 847–850. 10.3892/ol.2016.5458
203
Lo CiceroA.MajkowskaI.NagaseH.Di LiegroI.TroebergL. (2012). Microvesicles Shed by Oligodendroglioma Cells and Rheumatoid Synovial Fibroblasts Contain Aggrecanase Activity. Matrix Biol.31 (4), 229–233. 10.1016/j.matbio.2012.02.005
204
LongoR.BastienC.CampitielloM.PlastinoF.RozziA. (2020). Breast and Axillary Lymph Node Metastasis from Ovarian Cancer: A Case Report. Am. J. Case Rep.21, e925089. 10.12659/AJCR.925089
205
LuY.-J.YangY.YuanY.-H.WangW.-J.CuiM.-T.TangH.-Y.et al (2020). A Novel Nomogram Based on SEER Database for the Prediction of Liver Metastasis in Patients with Small-Cell Lung Cancer. Ann. Palliat. Med.9 (5), 3123–3137. 10.21037/apm-20-886
206
LuanW.DingY.XiH.RuanH.LuF.MaS.et al (2021). Exosomal miR-106b-5p Derived from Melanoma Cell Promotes Primary Melanocytes Epithelial-Mesenchymal Transition through Targeting EphA4. J. Exp. Clin. Cancer Res.40 (1), 107. 10.1186/s13046-021-01906-w
207
LudwigN.WhitesideT. L. (2018). Potential Roles of Tumor-Derived Exosomes in Angiogenesis. Expert Opin. Ther. Targets22 (5), 409–417. 10.1080/14728222.2018.1464141
208
LudwigS.FlorosT.TheodorakiM.-N.HongC.-S.JacksonE. K.LangS.et al (2017). Suppression of Lymphocyte Functions by Plasma Exosomes Correlates with Disease Activity in Patients with Head and Neck Cancer. Clin. Cancer Res.23 (16), 4843–4854. 10.1158/1078-0432.CCR-16-2819
209
LugaV.ZhangL.Viloria-PetitA. M.OgunjimiA. A.InanlouM. R.ChiuE.et al (2012). Exosomes Mediate Stromal Mobilization of Autocrine Wnt-PCP Signaling in Breast Cancer Cell Migration. Cell151 (7), 1542–1556. 10.1016/j.cell.2012.11.024
210
LuoK.-J.ChenC.-X.YangJ.-P.HuangY.-C.CardenasE. R.JiangJ. X. (2020a). Connexins in Lung Cancer and Brain Metastasis. Front. Oncol.10, 599383. 10.3389/fonc.2020.599383
211
LuoY.MaJ.LiuF.GuoJ.GuiR. (2020b). Diagnostic Value of Exosomal circMYC in Radioresistant Nasopharyngeal Carcinoma. Head & Neck42 (12), 3702–3711. 10.1002/hed.26441
212
LuoZ.RongZ.HuangC. (2019). Surgery Strategies for Gastric Cancer with Liver Metastasis. Front. Oncol.9, 1353. 10.3389/fonc.2019.01353
213
MaB.WellsA.WeiL.ZhengJ. (2021). Prostate Cancer Liver Metastasis: Dormancy and Resistance to Therapy. Semin. Cancer Biol.71, 2–9. 10.1016/j.semcancer.2020.07.004
214
MaJ.ZhangJ.WengY. C.WangJ. C. (2018). EZH2-Mediated microRNA-139-5p Regulates Epithelial-Mesenchymal Transition and Lymph Node Metastasis of Pancreatic Cancer. Mol. Cell41 (9), 868–880. 10.14348/molcells.2018.0109
215
MaR.YeX.ChengH.CuiH.ChangX. (2021). Tumor-derived Exosomal circRNA051239 Promotes Proliferation and Migration of Epithelial Ovarian Cancer. Am. J. Transl Res.13 (3), 1125–1139.
216
MaR.-Y.ZhangH.LiX.-F.ZhangC.-B.SelliC.TagliaviniG.et al (2020a). Monocyte-derived Macrophages Promote Breast Cancer Bone Metastasis Outgrowth. J. Exp. Med.217 (11). 10.1084/jem.20191820
217
MaR.FengY.LinS.ChenJ.LinH.LiangX.et al (2015). Mechanisms Involved in Breast Cancer Liver Metastasis. J. Transl Med.13, 64. 10.1186/s12967-015-0425-0
218
MaZ.-j.WangY.LiH.-f.LiuM.-H.BiF.-r.MaL.et al (2020b). LncZEB1-AS1 Regulates Hepatocellular Carcinoma Bone Metastasis via Regulation of the miR-302b-EGFR-Pi3k-AKT axis. J. Cancer11 (17), 5118–5128. 10.7150/jca.45995
219
MahabeleshwarG. H.ChenJ.FengW.SomanathP. R.RazorenovaO. V.ByzovaT. V. (2008). Integrin Affinity Modulation in Angiogenesis. Cell Cycle7 (3), 335–347. 10.4161/cc.7.3.5234
220
MahabeleshwarG. H.FengW.ReddyK.PlowE. F.ByzovaT. V. (2007). Mechanisms of Integrin-Vascular Endothelial Growth Factor Receptor Cross-Activation in Angiogenesis. Circ. Res.101 (6), 570–580. 10.1161/CIRCRESAHA.107.155655
221
MakinoH.NishioS.TsubamotoH.ShimadaM.NishikawaR.KaiK.et al (2016). Treatment and Prognosis of Bone Metastasis from Cervical Cancer (KCOG-G1202s). J. Obstet. Gynaecol. Res.42 (6), 701–706. 10.1111/jog.12956
222
MallaR. R.PandrangiS.KumariS.GavaraM. M.BadanaA. K. (2018). Exosomal Tetraspanins as Regulators of Cancer Progression and Metastasis and Novel Diagnostic Markers. Asia-pac J. Clin. Oncol.14 (6), 383–391. 10.1111/ajco.12869
223
MannavolaF.MandalaM.TodiscoA.SileniV. C.PallaM.MinisiniA. M.et al (2020). An Italian Retrospective Survey on Bone Metastasis in Melanoma: Impact of Immunotherapy and Radiotherapy on Survival. Front. Oncol.10, 1652. 10.3389/fonc.2020.01652
224
Marchand CretyC.EttalhaouiL.Servagi VernatS. (2020). Cystic Brain Metastasis from Prostate Cancer: A Case Report and Literature Review. Urol. Case Rep.32, 101219. 10.1016/j.eucr.2020.101219
225
MarzulloA.SerioG.PezzutoF.FortarezzaF.CazzatoG.CaporussoC.et al (2020). A Single Liver Metastasis from Pleural Biphasic Mesothelioma. Diagnostics10 (8), 555. 10.3390/diagnostics10080555
226
MatsumotoH.YoshidaY. (2015). Brain Metastasis from Pancreatic Cancer: A Case Report and Literature Review. Asian J. Neurosurg.10 (1), 35–39. 10.4103/1793-5482.151507
227
MatsumuraT.OhzatoH.YamamotoT.OtaK.MabuchiE.MiwaH.et al (2009). A Case of Postoperative Brain Metastasis Originated from Pancreatic Cancer Which Was Successfully Treated by Resection and Postoperative Irradiation. Gan To Kagaku Ryoho36 (12), 2433–2435.
228
MauriC.BosmaA. (2012). Immune Regulatory Function of B Cells. Annu. Rev. Immunol.30, 221–241. 10.1146/annurev-immunol-020711-074934
229
McCarthyD. H. (2001). Letters to the Editor. Prog. Transpl.11 (3), 162. 10.7182/prtr.11.3.hh6665126211678310.1177/152692480101100302
230
MerkowJ.PanicciaA.JonesE.JonesT.HodgesM.StovallR.et al (2016). Association of sentinel Lymph Node Diameter with Melanoma Metastasis. Am. J. Surg.212 (2), 315–320. 10.1016/j.amjsurg.2015.09.022
231
MermodM.BongiovanniM.PetrovaT.GounE.SimonC.TolstonogG.et al (2019). Prediction of Occult Lymph Node Metastasis in Head and Neck Cancer with CD31 Vessel Quantification. Otolaryngol. Head Neck Surg.160 (2), 277–283. 10.1177/0194599818791779
232
MikamiJ.KimuraY.MakariY.FujitaJ.KishimotoT.SawadaG.et al (2017). Clinical Outcomes and Prognostic Factors for Gastric Cancer Patients with Bone Metastasis. World J. Surg. Onc15 (1), 8. 10.1186/s12957-016-1091-2
233
MinciacchiV. R.FreemanM. R.Di VizioD. (2015). Extracellular Vesicles in Cancer: Exosomes, Microvesicles and the Emerging Role of Large Oncosomes. Semin. Cel Dev. Biol.40, 41–51. 10.1016/j.semcdb.2015.02.010
234
MoyA. P.MochelM. C.MuzikanskyA.DuncanL. M.KraftS. (2017). Lymphatic Invasion Predicts sentinel Lymph Node Metastasis and Adverse Outcome in Primary Cutaneous Melanoma. J. Cutan. Pathol.44 (9), 734–739. 10.1111/cup.12969
235
Muhsin-SharafaldineM.-R.SaundersonS. C.DunnA. C.McLellanA. D. (2017). Melanoma Growth and Lymph Node Metastasis Is Independent of Host CD169 Expression. Biochem. Biophysical Res. Commun.486 (4), 965–970. 10.1016/j.bbrc.2017.03.138
236
NabetB. Y.QiuY.ShabasonJ. E.WuT. J.YoonT.KimB. C.et al (2017). Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer. Cell170 (2), 352 e313–366. 10.1016/j.cell.2017.06.031
237
NagataA.KanemasaY.KikuchiM.OtaniR.YamadaR.MotoiT.et al (2020). Bone Marrow Metastasis of Glioblastoma Multiforme Mimicking Acute Myeloid Leukemia. Oxf Med. Case Rep.2020 (6), omaa040. 10.1093/omcr/omaa040
238
NagyJ. A.DvorakH. F. (2012). Heterogeneity of the Tumor Vasculature: the Need for New Tumor Blood Vessel Type-specific Targets. Clin. Exp. Metastasis29 (7), 657–662. 10.1007/s10585-012-9500-6
239
NakamaraN.MatsuiT.IshibashiY.SotokawauchiA.FukamiK.HigashimotoY.et al (2017b). RAGE-aptamer Attenuates the Growth and Liver Metastasis of Malignant Melanoma in Nude Mice. Mol. Med.23, 295–306. 10.2119/molmed.2017.00099
240
NakamuraK.SawadaK.KinoseY.YoshimuraA.TodaA.NakatsukaE.et al (2017a). Exosomes Promote Ovarian Cancer Cell Invasion through Transfer of CD44 to Peritoneal Mesothelial Cells. Mol. Cancer Res.15 (1), 78–92. 10.1158/1541-7786.MCR-16-0191
241
NamH. C.SungP. S.SongD. S.KwonJ. H.NamS. W.YoonD. J.et al (2019). Control of Intracranial Disease Is Associated with Improved Survival in Patients with Brain Metastasis from Hepatocellular Carcinoma. Int. J. Clin. Oncol.24 (6), 666–676. 10.1007/s10147-019-01407-z
242
NamburiS.BroxmeyerH. E.HongC.-S.WhitesideT. L.BoyiadzisM. (2021). DPP4+ Exosomes in AML Patients' Plasma Suppress Proliferation of Hematopoietic Progenitor Cells. Leukemia35 (7), 1925–1932. 10.1038/s41375-020-01047-7
243
NanceM. E.BiedermannG. B.BhatA. P.DavisR. M. (2020). Chemorefractory Liver Metastasis from Cervical Cancer Successfully Treated with a Combination of Yttrium-90 and Immunotherapy. Radiol. Case Rep.15 (8), 1359–1365. 10.1016/j.radcr.2020.06.010
244
NaoeH.KakuE.IdoY.GushimaR.MakiY.SaitoH.et al (2011). Brain Metastasis from Gastrointestinal Stromal Tumor: a Case Report and Review of the Literature. Case Rep. Gastroenterol.5 (3), 583–589. 10.1159/000333403
245
NartthanarungA.ThanapprapasrK.UdomsubpayakulU.ThanapprapasrD. (2014). Age and Survival of Cervical Cancer Patients with Bone Metastasis. Asian Pac. J. Cancer Prev.15 (19), 8401–8404. 10.7314/apjcp.2014.15.19.8401
246
NguyenD. X.BosP. D.MassaguéJ. (2009). Metastasis: from Dissemination to Organ-specific Colonization. Nat. Rev. Cancer9 (4), 274–284. 10.1038/nrc2622
247
NienstedtJ. C.SchroederC.ClauditzT.SimonR.SauterG.MuenscherA.et al (2018). EZH2 Overexpression in Head and Neck Cancer Is Related to Lymph Node Metastasis. J. Oral Pathol. Med.47 (3), 240–245. 10.1111/jop.12673
248
NieswandtB.HafnerM.EchtenacherB.MännelD. N. (1999). Lysis of Tumor Cells by Natural Killer Cells in Mice Is Impeded by Platelets. Cancer Res.59 (6), 1295–1300.
249
NishinoH.AbeK.IgarashiM.MiyataM.KitamuraK. (1996). Chemotherapy with Low-Dose Consecutive Cisplatin (Cddp) for Patients with Recurrent and Distant Metastasis of Head and Neck Cancer. Nippon Jibiinkoka Gakkai Kaiho99 (9), 1218–1222. 10.3950/jibiinkoka.99.1218
250
NishioN.van den BergN. S.MartinB. A.van KeulenS.FakurnejadS.RosenthalE. L.et al (2021). Photoacoustic Molecular Imaging for the Identification of Lymph Node Metastasis in Head and Neck Cancer Using an Anti-EGFR Antibody-Dye Conjugate. J. Nucl. Med.62 (5), 648–655. 10.2967/jnumed.120.245241
251
OharaH.IshibashiY.YoshimuraS.YamazakiR.HataoF.KoshiishiT.et al (2020). Intratumoral Pseudoaneurysm within a Liver Metastasis of Gastric Cancer: a Case Report. Surg. Case Rep.6 (1), 39. 10.1186/s40792-020-00806-z
252
OkabeH.AokiK.YogosawaS.SaitoM.MarumoK.YoshidaK. (2018). Downregulation of CD24 Suppresses Bone Metastasis of Lung Cancer. Cancer Sci.109 (1), 112–120. 10.1111/cas.13435
253
OutaniH.AkitaH.NakaiT.TakadaR.ImuraY.TanakaT.et al (2018). Clinical Features and Prognosis of Patients with the Bone Metastasis of Pancreatic Cancer. Pancreas47 (7), e43–e46. 10.1097/MPA.0000000000001098
254
PaceK. R.DuttR.GalileoD. S. (2019). Exosomal L1CAM Stimulates Glioblastoma Cell Motility, Proliferation, and Invasiveness. Ijms20 (16), 3982. 10.3390/ijms20163982
255
PahlJ.CerwenkaA. (2017). Tricking the Balance: NK Cells in Anti-cancer Immunity. Immunobiology222 (1), 11–20. 10.1016/j.imbio.2015.07.012
256
PakneshanS.SafarpourD.TavassoliF.JabbariB. (2014). Brain Metastasis from Ovarian Cancer: a Systematic Review. J. Neurooncol.119 (1), 1–6. 10.1007/s11060-014-1447-9
257
PaolettiC.HayesD. F. (2016). Circulating Tumor Cells. Adv. Exp. Med. Biol.882, 235–258. 10.1007/978-3-319-22909-6_10
258
PaolilloM.SchinelliS. (2017). Integrins and Exosomes, a Dangerous Liaison in Cancer Progression. Cancers9 (8), 95. 10.3390/cancers9080095
259
ParkJ.-M.HanY.-M.JeongM.ChungM. H.KwonC. I.KoK. H.et al (2017). Synthetic 8-hydroxydeoxyguanosine Inhibited Metastasis of Pancreatic Cancer through Concerted Inhibitions of ERM and Rho-GTPase. Free Radic. Biol. Med.110, 151–161. 10.1016/j.freeradbiomed.2017.06.003
260
ParkS.ByunH. K.SeongJ. (2019). Irradiation-Related Lymphopenia for Bone Metastasis from Hepatocellular Carcinoma. Liver Cancer8 (6), 468–479. 10.1159/000500461
261
ParkS. M.Do-ThiV. A.LeeJ. O.LeeH.KimY. S. (2020). Interleukin-9 Inhibits Lung Metastasis of Melanoma through Stimulating Anti-tumor M1 Macrophages. Mol. Cell43 (5), 479–490. 10.14348/molcells.2020.0047
262
PedrosaR. M. S. M.MustafaD. A.SoffiettiR.KrosJ. M. (2018). Breast Cancer Brain Metastasis: Molecular Mechanisms and Directions for Treatment. Neuro Oncol.20 (11), 1439–1449. 10.1093/neuonc/noy044
263
PeinadoH.AlečkovićM.LavotshkinS.MateiI.Costa-SilvaB.Moreno-BuenoG.et al (2012). Melanoma Exosomes Educate Bone Marrow Progenitor Cells toward a Pro-metastatic Phenotype through MET. Nat. Med.18 (6), 883–891. 10.1038/nm.2753
264
PeinadoH.LavotshkinS.LydenD. (2011). The Secreted Factors Responsible for Pre-metastatic Niche Formation: Old Sayings and New Thoughts. Semin. Cancer Biol.21 (2), 139–146. 10.1016/j.semcancer.2011.01.002
265
PeinadoH.ZhangH.MateiI. R.Costa-SilvaB.HoshinoA.RodriguesG.et al (2017). Pre-metastatic Niches: Organ-specific Homes for Metastases. Nat. Rev. Cancer17 (5), 302–317. 10.1038/nrc.2017.6
266
PengZ.XuS.LiH.SunC.FuM.GaoM. (2014). Advanced Gastric Cancer with Brain Metastasis Effectively Treated by Arterial Infusion Chemotherapy: A Case Report. Oncol. Lett.7 (2), 449–451. 10.3892/ol.2013.1699
267
PolistinaG. E.MatareseA.CarielloP.CaroppoD.ZamparelliA. S. (2020). Cavitary Lung Metastasis as Relapse of Prostate Cancer. Respir. Med. Case Rep.29, 100973. 10.1016/j.rmcr.2019.100973
268
ProvenzanoP. P.InmanD. R.EliceiriK. W.KnittelJ. G.YanL.RuedenC. T.et al (2008). Collagen Density Promotes Mammary Tumor Initiation and Progression. BMC Med.6, 11. 10.1186/1741-7015-6-11
269
PylayevaY.GillenK. M.GeraldW.BeggsH. E.ReichardtL. F.GiancottiF. G. (2009). Ras- and PI3K-dependent Breast Tumorigenesis in Mice and Humans Requires Focal Adhesion Kinase Signaling. J. Clin. Invest.119 (2), 252–266. 10.1172/JCI37160
270
QianB.-Z.PollardJ. W. (2010). Macrophage Diversity Enhances Tumor Progression and Metastasis. Cell141 (1), 39–51. 10.1016/j.cell.2010.03.014
271
QiuJ.-J.LinX.-J.TangX.-Y.ZhengT.-T.LinY.-Y.HuaK.-Q. (2018a). Exosomal Metastasis-Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer. Int. J. Biol. Sci.14 (14), 1960–1973. 10.7150/ijbs.28048
272
QiuM.-Z.ShiS.-M.ChenZ.-H.YuH.-E.ShengH.JinY.et al (2018b). Frequency and Clinicopathological Features of Metastasis to Liver, Lung, Bone, and Brain from Gastric Cancer: A SEER-Based Study. Cancer Med.7 (8), 3662–3672. 10.1002/cam4.1661
273
QiuX.JiangY.ZhaoQ.YanC.HuangM.JiangT. a. (2020). Could Ultrasound‐Based Radiomics Noninvasively Predict Axillary Lymph Node Metastasis in Breast Cancer?J. Ultrasound Med.39 (10), 1897–1905. 10.1002/jum.15294
274
RackovG.Garcia-RomeroN.Esteban-RubioS.Carrión-NavarroJ.Belda-IniestaC.Ayuso-SacidoA. (2018). Vesicle-Mediated Control of Cell Function: The Role of Extracellular Matrix and Microenvironment. Front. Physiol.9, 651. 10.3389/fphys.2018.00651
275
RamtekeA.TingH.AgarwalC.MateenS.SomasagaraR.HussainA.et al (2015). Exosomes Secreted under Hypoxia Enhance Invasiveness and Stemness of Prostate Cancer Cells by Targeting Adherens junction Molecules. Mol. Carcinog.54 (7), 554–565. 10.1002/mc.22124
276
RaposoG.StoorvogelW. (2013). Extracellular Vesicles: Exosomes, Microvesicles, and Friends. J. Cel Biol200 (4), 373–383. 10.1083/jcb.201211138
277
RedmerT. (2018). Deciphering Mechanisms of Brain Metastasis in Melanoma - the Gist of the Matter. Mol. Cancer17 (1), 106. 10.1186/s12943-018-0854-5
278
RenJ.DingL.ZhangD.ShiG.XuQ.ShenS.et al (2018). Carcinoma-associated Fibroblasts Promote the Stemness and Chemoresistance of Colorectal Cancer by Transferring Exosomal lncRNA H19. Theranostics8 (14), 3932–3948. 10.7150/thno.25541
279
RicardJ. A.CramerS. W.CharlesR.Gil TommeeC.LeA.BellW. R.et al (2019). Infratentorial Glioblastoma Metastasis to Bone. World Neurosurg.131, 90–94. 10.1016/j.wneu.2019.07.142
280
RobbinsP. D.MorelliA. E. (2014). Regulation of Immune Responses by Extracellular Vesicles. Nat. Rev. Immunol.14 (3), 195–208. 10.1038/nri3622
281
RoccaroA. M.SaccoA.MaisoP.AzabA. K.TaiY.-T.ReaganM.et al (2013). BM Mesenchymal Stromal Cell-Derived Exosomes Facilitate Multiple Myeloma Progression. J. Clin. Invest.123 (4), 1542–1555. 10.1172/JCI66517
282
RodriguesG.HoshinoA.KenificC. M.MateiI. R.SteinerL.FreitasD.et al (2019). Tumour Exosomal CEMIP Protein Promotes Cancer Cell Colonization in Brain Metastasis. Nat. Cel Biol21 (11), 1403–1412. 10.1038/s41556-019-0404-4
283
RoegelJ. C.BressolletteL.FouilhouxA. C.MartinF.MorandC.MottierD. (1993). Peritoneal Mesothelioma with Bone Metastasis: a Radionuclide Follow-Up. Ann. Med. Interne (Paris)144 (6), 425.
284
RyuS.-H.HeoS.-H.ParkE. Y.ChoiK.-C.RyuJ.-W.LeeS. H.et al (2017). Selumetinib Inhibits Melanoma Metastasis to Mouse Liver via Suppression of EMT-Targeted Genes. Ar37 (2), 607–614. 10.21873/anticanres.11354
285
SaidN. A. B. M.WilliamsE. D. (2011). Growth Factors in Induction of Epithelial-Mesenchymal Transition and Metastasis. Cells Tissues Organs193 (1-2), 85–97. 10.1159/000320360
286
SaifM. W.GalaninaN.Ravage-MassL.KaleyK.CornfeldD.LambL.et al (20102010). Bone Metastasis as the Only Metastatic Site in a Patient with Pancreatic Cancer Following Distal Pancreatectomy. Case Rep. Med.2010, 1–3. 10.1155/2010/634975
287
SakimuraC.HoriT.DeguchiS.MasudaG.TendoM.NakataB.et al (2019). A Case Report of Lung Resection for Lung Metastasis from Pancreatic Cancer. Gan To Kagaku Ryoho46 (13), 1934–1936.
288
SalvadorF.LlorenteA.GomisR. R. (2019). From Latency to Overt Bone Metastasis in Breast Cancer: Potential for Treatment and Prevention. J. Pathol.249 (1), 6–18. 10.1002/path.5292
289
SantarpiaM.LiguoriA.D’AveniA.KarachaliouN.Gonzalez-CaoM.DaffinàM. G.et al (2018). Liquid Biopsy for Lung Cancer Early Detection. J. Thorac. Dis.10 (Suppl. 7), S882–S897. 10.21037/jtd.2018.03.81
290
SasakiT.SatoT.NakaiY.SasahiraN.IsayamaH.KoikeK. (2019). Brain Metastasis in Pancreatic Cancer. Medicine (Baltimore)98 (4), e14227. 10.1097/MD.0000000000014227
291
SatoY.TanakaK.KobayashiY.ShibuyaH.NishigayaY.MomomuraM.et al (2015). Uterine Cervical Cancer with Brain Metastasis as the Initial Site of Presentation. J. Obstet. Gynaecol. Res.41 (7), 1145–1148. 10.1111/jog.12668
292
SchwarzD.NiederleT.MünchP.HielscherT.HasselJ. C.SchlemmerH. P.et al (2019). Susceptibility‐weighted Imaging in Malignant Melanoma Brain Metastasis. J. Magn. Reson. Imaging50 (4), 1251–1259. 10.1002/jmri.26692
293
SeifertA. M.EymerA.HeidukM.WehnerR.TungerA.von RenesseJ.et al (2020). PD-1 Expression by Lymph Node and Intratumoral Regulatory T Cells Is Associated with Lymph Node Metastasis in Pancreatic Cancer. Cancers12 (10), 2756. 10.3390/cancers12102756
294
SharmaD.Brummel-ZiedinsK. E.BouchardB. A.HolmesC. E. (2014). Platelets in Tumor Progression: a Host Factor that Offers Multiple Potential Targets in the Treatment of Cancer. J. Cel. Physiol229 (8), 1005–1015. 10.1002/jcp.24539
295
SharmaP.LudwigS.MullerL.HongC. S.KirkwoodJ. M.FerroneS.et al (2018a). Immunoaffinity-based Isolation of Melanoma Cell-Derived Exosomes from Plasma of Patients with Melanoma. J. Extracellular Vesicles7 (1), 1435138. 10.1080/20013078.2018.1435138
296
SharmaS.AlharbiM.KobayashiM.LaiA.GuanzonD.ZuñigaF.et al (2018b). Proteomic Analysis of Exosomes Reveals an Association between Cell Invasiveness and Exosomal Bioactivity on Endothelial and Mesenchymal Cell Migration In Vitro. Clin. Sci. (Lond)132 (18), 2029–2044. 10.1042/CS20180425
297
ShattilS. J.GinsbergM. H. (1997). Integrin Signaling in Vascular Biology. J. Clin. Invest.100 (11 Suppl. l), S91–S95. 10.1172/jci119500
298
SherwoodL. M.ParrisE. E.FolkmanJ. (1971). Tumor Angiogenesis: Therapeutic Implications. N. Engl. J. Med.285 (21), 1182–1186. 10.1056/NEJM197111182852108
299
ShidaY.HakariyaT.MiyataY.SakaiH. (2020). Three Cases of Brain Metastasis from Castration‐resistant Prostate Cancer. Clin. Case Rep.8 (1), 96–99. 10.1002/ccr3.2587
300
ShutoT.FujinoH.InomoriS.NakayamaS.SatohH.IdeguchiH.et al (1995). Glioblastoma Multiforme with Liver Metastasis-Ccase Report. No To Shinkei47 (8), 772–777.
301
SimonsB. W.DalrympleS.RosenM.ZhengL.BrennenW. N. (2020). A Hemi‐spleen Injection Model of Liver Metastasis for Prostate Cancer. Prostate80 (14), 1263–1269. 10.1002/pros.24055
302
SinghR.PochampallyR.WatabeK.LuZ.MoY.-Y. (2014). Exosome-mediated Transfer of miR-10b Promotes Cell Invasion in Breast Cancer. Mol. Cancer13, 256. 10.1186/1476-4598-13-256
303
SkogJ.WürdingerT.van RijnS.MeijerD. H.GaincheL.CurryW. T.et al (2008). Glioblastoma Microvesicles Transport RNA and Proteins that Promote Tumour Growth and Provide Diagnostic Biomarkers. Nat. Cel Biol10 (12), 1470–1476. 10.1038/ncb1800
304
Soler-CardonaA.ForsthuberA.LippK.EbersbergerS.HeinzM.SchossleitnerK.et al (2018). CXCL5 Facilitates Melanoma Cell-Neutrophil Interaction and Lymph Node Metastasis. J. Invest. Dermatol.138 (7), 1627–1635. 10.1016/j.jid.2018.01.035
305
SommersC. L.ByersS. W.ThompsonE. W.TorriJ. A.GelmannE. P. (1994). Differentiation State and Invasiveness of Human Breast Cancer Cell Lines. Breast Cancer Res. Tr31 (2-3), 325–335. 10.1007/BF00666165
306
SridharS.Paz-AresL.LiuH.ShenK.MorehouseC.RizviN.et al (2019). Prognostic Significance of Liver Metastasis in Durvalumab-Treated Lung Cancer Patients. Clin. Lung Cancer20 (6), e601–e608. 10.1016/j.cllc.2019.06.020
307
SruthiT. V.EdattL.RajiG. R.KunhiramanH.ShankarS. S.ShankarV.et al (2018). Horizontal Transfer of miR-23a from Hypoxic Tumor Cell Colonies Can Induce Angiogenesis. J. Cel Physiol233 (4), 3498–3514. 10.1002/jcp.26202
308
StanselT.A. WicklineS.PanH. (2020). NF-κB Inhibition Suppresses Experimental Melanoma Lung Metastasis. J. Cancer Sci. Clin. Ther.04 (3), 256–265. 10.26502/jcsct.5079070
309
StasenkoM.CybulskaP.FeitN.MakkerV.KonnerJ.O'CearbhaillR. E.et al (2019). Brain Metastasis in Epithelial Ovarian Cancer by BRCA1/2 Mutation Status. Gynecol. Oncol.154 (1), 144–149. 10.1016/j.ygyno.2019.05.004
310
SuY. Y.SunL.GuoZ. R.LiJ. C.BaiT. T.CaiX. X.et al (2019). Upregulated Expression of Serum Exosomal miR-375 and miR-1307 Enhance the Diagnostic Power of CA125 for Ovarian Cancer. J. Ovarian Res.12 (1), 6. 10.1186/s13048-018-0477-x
311
SunH.WangC.HuB.GaoX.ZouT.LuoQ.et al (2021). Exosomal S100A4 Derived from Highly Metastatic Hepatocellular Carcinoma Cells Promotes Metastasis by Activating STAT3. Sig Transduct Target. Ther.6 (1), 187. 10.1038/s41392-021-00579-3
312
SunL.HeM.XuN.XuD.-H.Ben-DavidY.YangZ.-Y.et al (2018). Regulation of RAB22A by Mir-193b Inhibits Breast Cancer Growth and Metastasis Mediated by Exosomes. Int. J. Oncol.53 (6), 2705–2714. 10.3892/ijo.2018.4571
313
SunS.LianX.LiuX.MaJ.HouX.ZhangF.et al (2020). Multimodal Therapy Is a Better Choice for Patients with Brain Metastasis from Cervical Cancer. CmarVol 12, 12395–12402. 10.2147/CMAR.S283673
314
SussmanJ.RosaiJ. (1990). Lymph Node Metastasis. Am. J. Surg. Pathol.14 (9), 819–828. 10.1097/00000478-199009000-00003
315
SuzukiK.YasudaT.NagaoK.HoriT.WatanabeK.KanamoriM.et al (2015). Bone Metastasis of a Gastrointestinal Stromal Tumor: A Report of Two Cases. Oncol. Lett.9 (4), 1814–1818. 10.3892/ol.2015.2976
316
SwayneL. C.HedigerR. G.WolffM. (1992). Bone Scan Detection of Pelvic Metastasis from Pleural Mesothelioma. Clin. Nucl. Med.17 (12), 965–966. 10.1097/00003072-199212000-00013
317
SzczepanskiM. J.SzajnikM.WelshA.WhitesideT. L.BoyiadzisM. (2011). Blast-derived Microvesicles in Sera from Patients with Acute Myeloid Leukemia Suppress Natural Killer Cell Function via Membrane-Associated Transforming Growth Factor- 1. Haematologica96 (9), 1302–1309. 10.3324/haematol.2010.039743
318
TaharaR. K.BrewerT. M.TheriaultR. L.UenoN. T. (2019). Bone Metastasis of Breast Cancer. Adv. Exp. Med. Biol.1152, 105–129. 10.1007/978-3-030-20301-6_7
319
TakeharaY.EndoS.MoriY.NakaharaK.TakayanagiD.ShimadaS.et al (2014). Malignant Peritoneal Mesothelioma with Lymph Node Metastasis that Originated in the Transverse colon. World J. Surg. Onc12, 112. 10.1186/1477-7819-12-112
320
TanS.XiaL.YiP.HanY.TangL.PanQ.et al (2020). Exosomal miRNAs in Tumor Microenvironment. J. Exp. Clin. Cancer Res.39 (1), 67. 10.1186/s13046-020-01570-6
321
TavernaS.FlugyA.SaievaL.KohnE. C.SantoroA.MeravigliaS.et al (2012). Role of Exosomes Released by Chronic Myelogenous Leukemia Cells in Angiogenesis. Int. J. Cancer130 (9), 2033–2043. 10.1002/ijc.26217
322
TaylorD. D.Gerçel-TaylorC.LyonsK. S.StansonJ.WhitesideT. L. (2003). T-cell Apoptosis and Suppression of T-Cell receptor/CD3-Zeta by Fas Ligand-Containing Membrane Vesicles Shed from Ovarian Tumors. Clin. Cancer Res.9 (14), 5113–5119.
323
TengY.RenY.HuX.MuJ.SamykuttyA.ZhuangX.et al (2017). MVP-mediated Exosomal Sorting of miR-193a Promotes colon Cancer Progression. Nat. Commun.8, 14448. 10.1038/ncomms14448
324
ThakurB. K.ZhangH.BeckerA.MateiI.HuangY.Costa-SilvaB.et al (2014). Double-stranded DNA in Exosomes: a Novel Biomarker in Cancer Detection. Cell Res24 (6), 766–769. 10.1038/cr.2014.44
325
ThéryC.OstrowskiM.SeguraE. (2009). Membrane Vesicles as Conveyors of Immune Responses. Nat. Rev. Immunol.9 (8), 581–593. 10.1038/nri2567
326
TianX.-P.WangC.-Y.JinX.-H.LiM.WangF.-W.HuangW.-J.et al (2019). Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Theranostics9 (7), 1965–1979. 10.7150/thno.30958
327
TianX.SunM.WuH.ChenC.LiH.QiuS.et al (2021). Exosome-derived miR-Let-7c Promotes Angiogenesis in Multiple Myeloma by Polarizing M2 Macrophages in the Bone Marrow Microenvironment. Leuk. Res.105, 106566. 10.1016/j.leukres.2021.106566
328
TokoroT.NakamuraK.HiroseA.NakanumaS.OkamotoK.KinoshitaJ.et al (2018). A Case of Colon Cancer with Brain, Liver and Lung Metastasis Successfully Treated with Bevacizumab Plus Xelox Therapy. Gan To Kagaku Ryoho45 (3), 521–523.
329
TuncerM.FaydaciG.AltinG.ErdoganB. A.KibarS.SanliA.et al (2014). Metastasis of Non-muscle-invasive Bladder Cancer into the Thyroid Gland: a Literature Review Accompanied by a Rare Case. Korean J. Urol.55 (3), 222–225. 10.4111/kju.2014.55.3.222
330
TyagiA.SharmaS.WuK.WuS.-Y.XingF.LiuY.et al (2021). Nicotine Promotes Breast Cancer Metastasis by Stimulating N2 Neutrophils and Generating Pre-metastatic Niche in Lung. Nat. Commun.12 (1), 474. 10.1038/s41467-020-20733-9
331
UbukataH.MotohashiG.TabuchiT.NagataH.KonishiS.TabuchiT. (2011). Overt Bone Metastasis and Bone Marrow Micrometastasis of Early Gastric Cancer. Surg. Today41 (2), 169–174. 10.1007/s00595-010-4389-7
332
UedaS.OokaH.YamaguchiM.HayashiH.OkayasuT. (1973). Case of Pulmonary Metastasis of Ovarian Cancer Erroneously Diagnosed and Treated as Pulmonary Tuberculosis for a Long Time. Nihon Kyobu Shikkan Gakkai Zasshi11 (11), 684–687.
333
UesatoY.TamashiroK.TakatsukiM. (2020). Long-term Survival after Repeated Resection for Lung Metastasis Originating from Pancreatic Cancer: a Case Report. Surg. Case Rep.6 (1), 66. 10.1186/s40792-020-00832-x
334
UluçkanÖ. (2019). Mouse Models of Melanoma Bone Metastasis. Methods Mol. Biol.1914, 343–348. 10.1007/978-1-4939-8997-3_19
335
UmezuT.TadokoroH.AzumaK.YoshizawaS.OhyashikiK.OhyashikiJ. H. (2014). Exosomal miR-135b Shed from Hypoxic Multiple Myeloma Cells Enhances Angiogenesis by Targeting Factor-Inhibiting HIF-1. Blood124 (25), 3748–3757. 10.1182/blood-2014-05-576116
336
ValadiH.EkströmK.BossiosA.SjöstrandM.LeeJ. J.LötvallJ. O. (2007). Exosome-mediated Transfer of mRNAs and microRNAs Is a Novel Mechanism of Genetic Exchange between Cells. Nat. Cel Biol9 (6), 654–659. 10.1038/ncb1596
337
ValastyanS.WeinbergR. A. (2011). Tumor Metastasis: Molecular Insights and Evolving Paradigms. Cell147 (2), 275–292. 10.1016/j.cell.2011.09.024
338
VouraE. B.RamjeesinghR. A.MontgomeryA. M. P.SiuC.-H. (2001). Involvement of Integrin αvβ3and Cell Adhesion Molecule L1 in Transendothelial Migration of Melanoma Cells. MBoC12 (9), 2699–2710. 10.1091/mbc.12.9.2699
339
WanL.PantelK.KangY. (2013). Tumor Metastasis: Moving New Biological Insights into the Clinic. Nat. Med.19 (11), 1450–1464. 10.1038/nm.3391
340
WangB.MaoJ.-h.WangB.-y.WangL.-x.WenH.-y.XuL.-j.et al (2020). Exosomal miR-1910-3p Promotes Proliferation, Metastasis, and Autophagy of Breast Cancer Cells by Targeting MTMR3 and Activating the NF-Κb Signaling Pathway. Cancer Lett.489, 87–99. 10.1016/j.canlet.2020.05.038
341
WangC.-F.PengS.-J.LiuR.-Q.YuY.-J.GeQ.-M.LiangR.-B.et al (2020). The Combination of CA125 and NSE Is Useful for Predicting Liver Metastasis of Lung Cancer. Dis. Markers2020, 1–10. 10.1155/2020/8850873
342
WangG.XuJ.QiY.XiuJ.LiR.HanM. (2019a). Distribution of Brain Metastasis from Lung Cancer. CmarVol 11, 9331–9338. 10.2147/CMAR.S222920
343
WangH.DengQ.LvZ.LingY.HouX.ChenZ.et al (2019b). N6-methyladenosine Induced miR-143-3p Promotes the Brain Metastasis of Lung Cancer via Regulation of VASH1. Mol. Cancer18 (1), 181. 10.1186/s12943-019-1108-x
344
WangH.WeiM.KangY.XingJ.ZhaoY. (2020). Circular RNA circ_PVT1 Induces Epithelial-Mesenchymal Transition to Promote Metastasis of Cervical Cancer. aging12 (20), 20139–20151. 10.18632/aging.103679
345
WangJ.GuanX.ZhangY.GeS.ZhangL.LiH.et al (2018a). Exosomal miR-27a Derived from Gastric Cancer Cells Regulates the Transformation of Fibroblasts into Cancer-Associated Fibroblasts. Cell Physiol Biochem49 (3), 869–883. 10.1159/000493218
346
WangJ.ZhangQ.WangD.YangS.ZhouS.XuH.et al (2020). Microenvironment‐induced TIMP2 Loss by Cancer‐secreted Exosomal miR‐4443 Promotes Liver Metastasis of Breast Cancer. J. Cel Physiol235 (7-8), 5722–5735. 10.1002/jcp.29507
347
WangL.TantaiJ.ZhuX. (2020). Katanin P60: a Potential Biomarker for Lymph Node Metastasis and Prognosis for Non-small Cell Lung Cancer. World J. Surg. Onc18 (1), 157. 10.1186/s12957-020-01939-z
348
WangM.ChaoC.-C.ChenP.-C.LiuP.-I.YangY.-C.SuC.-M.et al (2019c). Thrombospondin Enhances RANKL-dependent Osteoclastogenesis and Facilitates Lung Cancer Bone Metastasis. Biochem. Pharmacol.166, 23–32. 10.1016/j.bcp.2019.05.005
349
WangM.ZhouJ.ZhangL.ZhaoY.ZhangN.WangL.et al (2019d). Surgical Treatment of Ovarian Cancer Liver Metastasis. Hepatobiliary Surg. Nutr.8 (2), 129–137. 10.21037/hbsn.2018.12.06
350
WangN.FengY.XieJ.HanH.DongQ.WangW. (2020). Long Non-coding RNA ZNF667-AS1 Knockdown Curbs Liver Metastasis in Acute Myeloid Leukemia by Regulating the microRNA-206/AKAP13 Axis. CmarVol 12, 13285–13300. 10.2147/CMAR.S269258
351
WangQ.WangG.NiuL.ZhaoS.LiJ.ZhangZ.et al (2021a). Exosomal MiR-1290 Promotes Angiogenesis of Hepatocellular Carcinoma via Targeting SMEK1. J. Oncol.2021, 1–13. 10.1155/2021/6617700
352
WangX.HuL.-P.QinW.-T.YangQ.ChenD.-Y.LiQ.et al (2021b). Identification of a Subset of Immunosuppressive P2RX1-Negative Neutrophils in Pancreatic Cancer Liver Metastasis. Nat. Commun.12 (1), 174. 10.1038/s41467-020-20447-y
353
WangX.LuoG.ZhangK.CaoJ.HuangC.JiangT.et al (2018). Hypoxic Tumor-Derived Exosomal miR-301a Mediates M2 Macrophage Polarization via PTEN/PI3Kγ to Promote Pancreatic Cancer Metastasis. Cancer Res.78 (16), 4586–4598. 10.1158/0008-5472.CAN-17-3841
354
WangX.WangB.ZhanW.KangL.ZhangS.ChenC.et al (2019e). Melatonin Inhibits Lung Metastasis of Gastric Cancer In Vivo. Biomed. Pharmacother.117, 109018. 10.1016/j.biopha.2019.109018
355
WangX.WangX.ZhuZ.LiW.YuG.JiaZ.et al (2019f). Prostate Carcinoma Cell-Derived Exosomal MicroRNA-26a Modulates the Metastasis and Tumor Growth of Prostate Carcinoma. Biomed. Pharmacother.117, 109109. 10.1016/j.biopha.2019.109109
356
WangY.LiuW.YuY.LiuJ.-j.XueH.-d.QiY.-f.et al (2020). CT Radiomics Nomogram for the Preoperative Prediction of Lymph Node Metastasis in Gastric Cancer. Eur. Radiol.30 (2), 976–986. 10.1007/s00330-019-06398-z
357
WaqarS. N.SamsonP. P.RobinsonC. G.BradleyJ.DevarakondaS.DuL.et al (2018). Non-small-cell Lung Cancer with Brain Metastasis at Presentation. Clin. Lung Cancer19 (4), e373–e379. 10.1016/j.cllc.2018.01.007
358
WebberJ.SteadmanR.MasonM. D.TabiZ.ClaytonA. (2010). Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation. Cancer Res.70 (23), 9621–9630. 10.1158/0008-5472.CAN-10-1722
359
WellsA.YatesC.ShepardC. R. (2008). E-cadherin as an Indicator of Mesenchymal to Epithelial Reverting Transitions during the Metastatic Seeding of Disseminated Carcinomas. Clin. Exp. Metastasis25 (6), 621–628. 10.1007/s10585-008-9167-1
360
WenS.WeiY.ZenC.XiongW.NiuY.ZhaoY. (2020). Long Non-coding RNA NEAT1 Promotes Bone Metastasis of Prostate Cancer through N6-Methyladenosine. Mol. Cancer19 (1), 171. 10.1186/s12943-020-01293-4
361
WernerssonS.PejlerG. (2014). Mast Cell Secretory Granules: Armed for Battle. Nat. Rev. Immunol.14 (7), 478–494. 10.1038/nri3690
362
WuH.SongS.YanA.GuoX.ChangL.XuL.et al (2020). RACK1 Promotes the Invasive Activities and Lymph Node Metastasis of Cervical Cancer via Galectin-1. Cancer Lett.469, 287–300. 10.1016/j.canlet.2019.11.002
363
WuJ.LiH.XieH.WuX.LanP. (2019). The Malignant Role of Exosomes in the Communication Among Colorectal Cancer Cell, Macrophage and Microbiome. Carcinogenesis40 (5), 601–610. 10.1093/carcin/bgy138
364
XiaY.ZhangB.ZhangH.LiW.WangK. P.ShenH. (2015). Evaluation of Lymph Node Metastasis in Lung Cancer: Who Is the Chief justice?J. Thorac. Dis.7 (Suppl. 4), S231–S237. 10.3978/j.issn.2072-1439.2015.11.63
365
XianX.GopalS.CouchmanJ. R. (2010). Syndecans as Receptors and Organizers of the Extracellular Matrix. Cell Tissue Res339 (1), 31–46. 10.1007/s00441-009-0829-3
366
XiaoD.BarryS.KmetzD.EggerM.PanJ.RaiS. N.et al (2016). Melanoma Cell-Derived Exosomes Promote Epithelial-Mesenchymal Transition in Primary Melanocytes through Paracrine/autocrine Signaling in the Tumor Microenvironment. Cancer Lett.376 (2), 318–327. 10.1016/j.canlet.2016.03.050
367
XieZ.GaoY.HoC.LiL.JinC.WangX.et al (2021). Exosome-delivered CD44v6/C1QBP Complex Drives Pancreatic Cancer Liver Metastasis by Promoting Fibrotic Liver Microenvironment. Gut71, 568–579. 10.1136/gutjnl-2020-323014
368
XingF.LiuY.WuS.-Y.WuK.SharmaS.MoY.-Y.et al (2018). Loss of XIST in Breast Cancer Activates MSN-C-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis. Cancer Res.78 (15), 4316–4330. 10.1158/0008-5472.CAN-18-1102
369
XuD.LinX.QiuX. (2020a). The Epithelioid Gastrointestinal Stromal Tumor with Pulmonary Metastasis. Medicine (Baltimore)99 (9), e19346. 10.1097/MD.0000000000019346
370
XuH.XuG. L.LiX. D.SuQ. H.DongC. Z. (2021). Correlation between the Contrast-Enhanced Ultrasound Image Features and Axillary Lymph Node Metastasis of Primary Breast Cancer and its Diagnostic Value. Clin. Transl Oncol.23 (1), 155–163. 10.1007/s12094-020-02407-6
371
XuL.XueF.WangB.YanD.DingW.YinJ.et al (2016). Hoarseness Due to Lymph Node Metastasis of Hepatocellular Carcinoma: A Case Report. Oncol. Lett.12 (2), 918–920. 10.3892/ol.2016.4687
372
XuN.ChenS. H.LinT. T.CaiH.KeZ. B.DongR. N.et al (2020b). Development and Validation of Hub Genes for Lymph Node Metastasis in Patients with Prostate Cancer. J. Cel Mol Med24 (8), 4402–4414. 10.1111/jcmm.15098
373
XuY. Y.LuX.MaoY. L.XiongJ. P.BianJ.HuangH. C.et al (2017). The Surgical Treatment of Ovarian Cancer Metastasis between Liver and Diaphragm: a Report of 83 Cases. Zhonghua Wai Ke Za Zhi55 (11), 838–841. 10.3760/cma.j.issn.0529-5815.2017.11.004
374
YamakawaY.MoriguchiM.AramakiT.MitsuyaK.AsakuraK.SawadaA.et al (2015). Brain Metastasis from Hepatocellular Carcinoma: The Impact of Radiotherapy on Control of Intracranial Hemorrhage. Hepatol. Res.45 (11), 1071–1075. 10.1111/hepr.12457
375
YamanakaT.TakakiH.NakatsukaA.UrakiJ.FujimoriM.HasegawaT.et al (2013). Radiofrequency Ablation for Liver Metastasis from Gastrointestinal Stromal Tumor. J. Vasc. Interv. Radiol.24 (3), 341–346. 10.1016/j.jvir.2012.11.021
376
YamashitaK.BabaY.KurashigeJ.IwatsukiM.ImaiK.HashimotoD.et al (2016). Co-occurrence of Liver Metastasis of Gastrointestinal Stromal Tumor and Hepatocellular Carcinoma: a Case Report. Surg. Case Rep.2 (1), 86. 10.1186/s40792-016-0212-z
377
YanT. D.YooD.SugarbakerP. H. (2006). Significance of Lymph Node Metastasis in Patients with Diffuse Malignant Peritoneal Mesothelioma. Eur. J. Surg. Oncol. (Ejso)32 (9), 948–953. 10.1016/j.ejso.2006.05.009
378
YangB.FengX.LiuH.TongR.WuJ.LiC.et al (2020a). High-metastatic Cancer Cells Derived Exosomal miR92a-3p Promotes Epithelial-Mesenchymal Transition and Metastasis of Low-Metastatic Cancer Cells by Regulating PTEN/Akt Pathway in Hepatocellular Carcinoma. Oncogene39 (42), 6529–6543. 10.1038/s41388-020-01450-5
379
YangG.-L.LuoT.-H.ZhangH.-Q.LingC.-Q.LiB. (2016). A Case Report of Gastric Cancer with Brain Metastasis: Rare Peripheral Nervous System Symptoms. Oncol. Lett.11 (4), 2893–2895. 10.3892/ol.2016.4288
380
YangH.ZhangH.GeS.NingT.BaiM.LiJ.et al (2018). Exosome-Derived miR-130a Activates Angiogenesis in Gastric Cancer by Targeting C-MYB in Vascular Endothelial Cells. Mol. Ther.26 (10), 2466–2475. 10.1016/j.ymthe.2018.07.023
381
YangS.-S.MaS.DouH.LiuF.ZhangS.-Y.JiangC.et al (2020b). Breast Cancer-Derived Exosomes Regulate Cell Invasion and Metastasis in Breast Cancer via miR-146a to Activate Cancer Associated Fibroblasts in Tumor Microenvironment. Exp. Cel Res.391 (2), 111983. 10.1016/j.yexcr.2020.111983
382
YaoK.PengC.ZhangY.ZykovaT. A.LeeM.-H.LeeS.-Y.et al (2017). RSK2 Phosphorylates T-Bet to Attenuate colon Cancer Metastasis and Growth. Proc. Natl. Acad. Sci. USA114 (48), 12791–12796. 10.1073/pnas.1710756114
383
YeL.ZhangF.LiH.YangL.LvT.GuW.et al (2017). Circulating Tumor Cells Were Associated with the Number of T Lymphocyte Subsets and NK Cells in Peripheral Blood in Advanced Non-small-cell Lung Cancer. Dis. Markers2017, 1–6. 10.1155/2017/5727815
384
YeL.ZhangQ.ChengY.ChenX.WangG.ShiM.et al (2018). Tumor-derived Exosomal HMGB1 Fosters Hepatocellular Carcinoma Immune Evasion by Promoting TIM-1+ Regulatory B Cell Expansion. J. Immunotherapy Cancer6 (1), 145. 10.1186/s40425-018-0451-6
385
YiH.YeJ.YangX. M.ZhangL. W.ZhangZ. G.ChenY. P. (2015). High-grade Ovarian Cancer Secreting Effective Exosomes in Tumor Angiogenesis. Int. J. Clin. Exp. Pathol.8 (5), 5062–5070.
386
YinZ.MaT.HuangB.LinL.ZhouY.YanJ.et al (2019). Macrophage-derived Exosomal microRNA-501-3p Promotes Progression of Pancreatic Ductal Adenocarcinoma through the TGFBR3-Mediated TGF-β Signaling Pathway. J. Exp. Clin. Cancer Res.38 (1), 310. 10.1186/s13046-019-1313-x
387
YoonA.ChoiC. H.KimH.-J.ParkJ.-Y.LeeY.-Y.KimT.-J.et al (2013). Contributing Factors for Bone Metastasis in Uterine Cervical Cancer. Int. J. Gynecol. Cancer23 (7), 1311–1317. 10.1097/IGC.0b013e31829da127
388
YorkJ. E.StringerJ.AjaniJ. A.WildrickD. M.GokaslanZ. L. (1999). Gastric Cancer and Metastasis to the Brain. Ann. Surg. Oncol.6 (8), 771–776. 10.1007/s10434-999-0771-3
389
YoshidaY.HoshinoS.MiyakeT.FukudaS.YamadaK.NaoyaA.et al (2012). Early Start of Chemotherapy after Resection of Brain Metastasis from colon Cancer with Synchronous Multiple Liver Metastases. Case Rep. Oncol.5 (2), 290–295. 10.1159/000339614
390
YouL.-N.TaiQ.-W.XuL.HaoY.GuoW.-J.ZhangQ.et al (2021a). Exosomal LINC00161 Promotes Angiogenesis and Metastasis via Regulating miR-590-3p/ROCK axis in Hepatocellular Carcinoma. Cancer Gene Ther.28 (6), 719–736. 10.1038/s41417-020-00269-2
391
YouX.WangY.MengJ.HanS.LiuL.SunY.et al (2021b). Exosomal miR-663b E-xposed to TGF-β1 P-romotes C-ervical C-ancer M-etastasis and E-pithelial-mesenchymal T-ransition by T-argeting MGAT3. Oncol. Rep.45 (4). 10.3892/or.2021.7963
392
YouY.ShanY.ChenJ.YueH.YouB.ShiS.et al (2015). Matrix Metalloproteinase 13‐containing Exosomes Promote Nasopharyngeal Carcinoma Metastasis. Cancer Sci.106 (12), 1669–1677. 10.1111/cas.12818
393
YousefiM.NosratiR.SalmaninejadA.DehghaniS.ShahryariA.SaberiA. (2018). Organ-specific Metastasis of Breast Cancer: Molecular and Cellular Mechanisms Underlying Lung Metastasis. Cell Oncol.41 (2), 123–140. 10.1007/s13402-018-0376-6
394
YuL.-X.YanL.YangW.WuF.-Q.LingY.ChenS.-Z.et al (2014). Platelets Promote Tumour Metastasis via Interaction between TLR4 and Tumour Cell-Released High-Mobility Group Box1 Protein. Nat. Commun.5, 5256. 10.1038/ncomms6256
395
YueS.MuW.ErbU.ZöllerM. (2015). The Tetraspanins CD151 and Tspan8 Are Essential Exosome Components for the Crosstalk between Cancer Initiating Cells and Their Surrounding. Oncotarget6 (4), 2366–2384. 10.18632/oncotarget.2958
396
YungW. K. A.TepperS. J.YoungD. F. (1983). Diffuse Bone Marrow Metastasis by Glioblastoma: Premortem Diagnosis by Peroxidase-Antiperoxidase Staining for Glial Fibrillary Acidic Protein. Ann. Neurol.14 (5), 581–585. 10.1002/ana.410140514
397
ZengZ.LiY.PanY.LanX.SongF.SunJ.et al (2018). Cancer-derived Exosomal miR-25-3p Promotes Pre-metastatic Niche Formation by Inducing Vascular Permeability and Angiogenesis. Nat. Commun.9 (1), 5395. 10.1038/s41467-018-07810-w
398
ZhangC.LiaoY.LiuP.DuQ.LiangY.OoiS.et al (2020). FABP5 Promotes Lymph Node Metastasis in Cervical Cancer by Reprogramming Fatty Acid Metabolism. Theranostics10 (15), 6561–6580. 10.7150/thno.44868
399
ZhangG.ZhangW.LiB.Stringer-ReasorE.ChuC.SunL.et al (2017). MicroRNA-200c and microRNA- 141 Are Regulated by a FOXP3-Kat2b axis and Associated with Tumor Metastasis in Breast Cancer. Breast Cancer Res.19 (1), 73. 10.1186/s13058-017-0858-x
400
ZhangH.-G.KimH.LiuC.YuS.WangJ.GrizzleW. E.et al (2007). Curcumin Reverses Breast Tumor Exosomes Mediated Immune Suppression of NK Cell Tumor Cytotoxicity. Biochim. Biophys. Acta (Bba) - Mol. Cel Res.1773 (7), 1116–1123. 10.1016/j.bbamcr.2007.04.015
401
ZhangH.DengT.LiuR.BaiM.ZhouL.WangX.et al (2017). Exosome-delivered EGFR Regulates Liver Microenvironment to Promote Gastric Cancer Liver Metastasis. Nat. Commun.8, 15016. 10.1038/ncomms15016
402
ZhangJ.GaoY.HanH.ZouC.FengY.ZhangH. (2019a). Matrine Suppresses Lung Metastasis of Human Hepatocellular Carcinoma by Directly Targeting Matrix Metalloproteinase-9. Biochem. Biophysical Res. Commun.515 (1), 57–63. 10.1016/j.bbrc.2019.04.063
403
ZhangL.NiuH.MaJ.YuanB.-Y.ChenY.-H.ZhuangY.et al (2019b). The Molecular Mechanism of LncRNA34a-Mediated Regulation of Bone Metastasis in Hepatocellular Carcinoma. Mol. Cancer18 (1), 120. 10.1186/s12943-019-1044-9
404
ZhangM.SunJ. (2013). Bone Metastasis from Ovarian Cancer. Clinical Analysis of 26 Cases. Saudi Med. J.34 (12), 1270–1273.
405
ZhangQ.LenT. Y.ZhangS. X.ZhaoQ. H.YangL. H. (2020). Exosomes Transferring Long Non-coding RNA FAL1 to Regulate Ovarian Cancer Metastasis through the PTEN/AKT Signaling Pathway. Eur. Rev. Med. Pharmacol. Sci.24 (21), 10921. 10.26355/eurrev_202011_23560
406
ZhangQ.SuoJ.ChangW.ShiJ.ChenM. (2017). Dual-modal Computer-Assisted Evaluation of Axillary Lymph Node Metastasis in Breast Cancer Patients on Both Real-Time Elastography and B-Mode Ultrasound. Eur. J. Radiol.95, 66–74. 10.1016/j.ejrad.2017.07.027
407
ZhangX. (2019). Interactions between Cancer Cells and Bone Microenvironment Promote Bone Metastasis in Prostate Cancer. Cancer Commun.39 (1), 76. 10.1186/s40880-019-0425-1
408
ZhangY.-F.ZhouY.-Z.ZhangB.HuangS.-F.LiP.-P.HeX.-M.et al (2019c). Pancreatic Cancer-Derived Exosomes Promoted Pancreatic Stellate Cells Recruitment by Pancreatic Cancer. J. Cancer10 (18), 4397–4407. 10.7150/jca.27590
409
ZhangZ.LiX.SunW.YueS.YangJ.LiJ.et al (2017). Loss of Exosomal miR-320a from Cancer-Associated Fibroblasts Contributes to HCC Proliferation and Metastasis. Cancer Lett.397, 33–42. 10.1016/j.canlet.2017.03.004
410
ZhaoZ.LiangS.SunF. (2020). LncRNA DLX6-AS1 Promotes Malignant Phenotype and Lymph Node Metastasis in Prostate Cancer by Inducing LARGE Methylation. Front. Oncol.10, 1172. 10.3389/fonc.2020.01172
411
ZhengX.MaN.WangX.HuJ.MaX.WangJ.et al (2020). Exosomes Derived from 5-Fluorouracil-Resistant colon Cancer Cells Are Enriched in GDF15 and Can Promote Angiogenesis. J. Cancer11 (24), 7116–7126. 10.7150/jca.49224
412
ZhongY.LuQ.QiuW.LuoY. (2020). LINC00636 Promotes Lymph Node Metastasis and Cervical Cancer through Targeting NM23. Biosci. Rep.40 (10). 10.1042/BSR20200367
413
ZhouC.-F.MaJ.HuangL.YiH.-Y.ZhangY.-M.WuX.-G.et al (2019). Cervical Squamous Cell Carcinoma-Secreted Exosomal miR-221-3p Promotes Lymphangiogenesis and Lymphatic Metastasis by Targeting VASH1. Oncogene38 (8), 1256–1268. 10.1038/s41388-018-0511-x
414
ZhouJ.SunJ.-Y.WuS.-G.WangX.HeZ.-Y.ChenQ.-H.et al (2016). Risk Factors for Lymph Node Metastasis in Ovarian Cancer: Implications for Systematic Lymphadenectomy. Int. J. Surg.29, 123–127. 10.1016/j.ijsu.2016.03.039
415
ZhouW.FongM. Y.MinY.SomloG.LiuL.PalomaresM. R.et al (2014). Cancer-secreted miR-105 Destroys Vascular Endothelial Barriers to Promote Metastasis. Cancer Cell25 (4), 501–515. 10.1016/j.ccr.2014.03.007
416
ZhouX.YanT.HuangC.XuZ.WangL.JiangE.et al (2018). Melanoma Cell-Secreted Exosomal miR-155-5p Induce Proangiogenic Switch of Cancer-Associated Fibroblasts via SOCS1/JAK2/STAT3 Signaling Pathway. J. Exp. Clin. Cancer Res.37 (1), 242. 10.1186/s13046-018-0911-3
417
ZhouZ.ChenL.SherD.ZhangQ.ShahJ.PhamN.-L.et al (2018). Predicting Lymph Node Metastasis in Head and Neck Cancer by Combining Many-objective Radiomics and 3-dimensioal Convolutional Neural Network through Evidential Reasoning*. Annu. Int. Conf. IEEE Eng. Med. Biol. Soc., 1–4. 10.1109/EMBC.2018.8513070
418
ZhuH.JiaZ.TrushM. A.LiY. R. (2016). Nrf2 Deficiency Promotes Melanoma Growth and Lung Metastasis. Ros2 (4), 308–314. 10.20455/ros.2016.853
419
ZhuY.-J.ChenY.HuH.-Y.ZhouY.-W.ZhuY.-T.LiuJ.-Y. (2020). Predictive Risk Factors and Online Nomograms for Synchronous Colon Cancer with Liver Metastasis. Front. Oncol.10, 1681. 10.3389/fonc.2020.01681
420
ZhuoS.ZhouJ.RuanG.ZengS.MaH.XieC.et al (2020). Percutaneous Microwave Ablation versus Surgical Resection for Ovarian Cancer Liver Metastasis. Int. J. Hyperthermia37 (1), 28–36. 10.1080/02656736.2019.1706767
421
ZongZ.-H.DuY.-P.GuanX.ChenS.ZhaoY. (2019). CircWHSC1 Promotes Ovarian Cancer Progression by Regulating MUC1 and hTERT through Sponging miR-145 and miR-1182. J. Exp. Clin. Cancer Res.38 (1), 437. 10.1186/s13046-019-1437-z
422
ZucchellaM.DezzaL.PacchiariniL.MeloniF.TacconiF.BonomiE.et al (1989). Human Tumor Cells Cultured "In Vitro" Activate Platelet Function by Producing ADP or Thrombin. Haematologica74 (6), 541–545.
Summary
Keywords
tumor-derived exosomes, metastasis, pre-metastatic niche, angiogenesis, immunosuppression
Citation
Bai S, Wang Z, Wang M, Li J, Wei Y, Xu R and Du J (2022) Tumor-Derived Exosomes Modulate Primary Site Tumor Metastasis. Front. Cell Dev. Biol. 10:752818. doi: 10.3389/fcell.2022.752818
Received
03 August 2021
Accepted
10 February 2022
Published
02 March 2022
Volume
10 - 2022
Edited by
Peti Thuwajit, Mahidol University, Thailand
Reviewed by
Nabanita Chatterjee, The Ohio State University, United States
Paola Massimi, International Centre for Genetic Engineering and Biotechnology, Italy
Updates
Copyright
© 2022 Bai, Wang, Wang, Li, Wei, Xu and Du.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Juan Du, dujuan@cuhk.edu.cn
†These authors have contributed equally to this work and share first authorship
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Cell and Developmental Biology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.